rfhg_93715.1

Basic information about the TSS

---

TSS ID: rfhg_93715.1 Species: human Chr: chr7		Start: 39624360 End: 39624361 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3968971,EH38E2550266)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000436179.1:-474 GeneID: 5898 HGNC/MGI_ID: HGNC:9839 UniProt_ID: C9JPE8 Nearer transcript ids and distances:

Gene_name: RAS like proto-oncogene A Gene_symbol: RALA Gene_synonyms: Gene_source: HGNC:9839

TATA-Box annotation

---

Distance to TSS:	788
Nearest PromoterID:	NM_005402
Entrez ID:	5898
Nearest Unigene:	Hs.6906
Nearest Refseq:	NM_005402
Nearest Ensembl:	ENSG00000006451
Gene Name:	RAS like proto-oncogene A
Gene Alias:	RAL
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.500000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RALA p2@RALA p3@RALA p4@RALA p5@RALA p6@RALA p9@RALA p10@RALA
Sample		p1@RALA	p2@RALA	p3@RALA	p4@RALA	p5@RALA	p6@RALA	p9@RALA	p10@RALA
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	30.19	6.04	2.14	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	26.50	7.28	0.81	0.61	0.40	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	31.06	5.59	0.96	0.19	0.00	0.00	0.00	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	27.86	6.24	2.49	0.21	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	29.47	7.65	2.02	0.22	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	28.88	6.59	0.97	0.00	0.39	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	42.05	9.59	2.18	0.22	0.00	0.00	0.00	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	38.51	6.54	0.73	0.24	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	30.13	4.27	1.07	0.21	0.00	0.00	0.00	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	33.62	6.38	1.16	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	35.57	4.04	0.81	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	28.05	7.32	0.41	0.81	0.00	0.00	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	28.05	9.35	1.77	0.16	0.16	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	26.61	5.86	1.50	0.45	0.30	0.00	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	27.01	8.56	3.07	0.00	0.22	0.00	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	20.37	6.79	2.26	0.75	0.25	0.00	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	24.02	7.43	1.97	0.44	0.00	0.00	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	27.00	6.75	2.95	0.00	0.00	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	19.19	13.86	3.73	0.53	0.53	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	23.17	10.08	3.76	0.30	0.75	0.15	0.00	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	27.13	12.96	3.21	0.13	0.40	0.00	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	23.82	7.77	2.07	0.35	0.35	0.17	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	26.50	12.80	3.23	0.52	0.65	0.13	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	27.66	10.92	3.15	0.73	0.49	0.00	0.00	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	27.60	9.03	3.35	0.77	0.77	0.00	0.00	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	24.69	13.93	3.80	0.00	0.63	0.00	0.00	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	21.43	11.54	4.95	0.00	0.55	0.00	0.00	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	33.01	15.56	4.24	0.47	0.47	0.00	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	26.33	11.79	4.85	0.65	0.00	0.00	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	30.40	13.75	4.71	0.72	0.54	0.18	0.00	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	25.54	17.17	7.12	0.42	1.47	0.00	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	26.38	15.83	3.32	0.78	1.76	0.00	0.00	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	31.02	13.51	4.22	2.53	0.63	0.21	0.00	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	32.33	22.27	6.43	0.66	0.33	0.00	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	28.80	20.57	3.18	0.93	0.37	0.37	0.00	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	38.13	20.70	4.98	0.77	0.96	0.00	0.00	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	36.79	22.89	6.74	1.64	1.43	0.00	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	33.85	17.53	5.84	0.81	1.01	0.00	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	41.06	24.04	8.10	0.81	2.16	0.27	0.00	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	36.73	28.33	5.76	0.48	1.92	0.48	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	33.41	21.88	3.53	0.94	1.65	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	33.67	23.28	5.86	1.90	1.02	0.00	0.00	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	37.33	22.57	7.17	1.27	1.69	0.21	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	37.76	30.07	5.77	1.22	2.10	0.00	0.00	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	40.96	29.31	5.82	0.80	2.41	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	43.27	26.75	7.68	1.40	3.72	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	44.38	29.03	9.60	2.88	2.16	0.72	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	51.56	34.57	9.24	2.09	2.09	0.89	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	48.35	39.26	10.53	0.96	4.31	0.24	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	45.90	34.58	10.72	2.22	3.44	0.40	0.00	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	50.01	36.07	9.22	1.02	3.07	0.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	42.47	42.03	7.56	1.11	4.89	0.44	0.00	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	489.73	293.84	83.95	97.95	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	52.87	35.84	6.03	1.06	3.19	0.35	0.00	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	41.09	32.48	6.30	1.33	1.66	0.33	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	94.80	90.61	14.26	2.52	3.36	0.00	1.68	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	46.38	48.22	8.73	1.84	1.84	0.46	0.92	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	48.62	44.08	9.40	0.97	4.86	0.32	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	48.18	44.64	4.82	0.32	4.50	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	48.41	44.01	6.29	2.51	3.77	0.00	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	35.96	34.55	7.05	1.41	2.82	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	36.45	42.62	9.53	1.68	2.80	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	54.93	59.71	5.57	2.39	2.39	0.00	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	39.75	50.29	8.49	0.68	4.08	0.00	0.34	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	61.41	55.24	15.92	1.30	3.57	0.65	0.00	2.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	46.86	53.96	12.42	1.77	4.61	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	501.08	420.26	113.15	32.33	0.00	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	663.39	371.18	86.87	15.79	0.00	0.00	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	31.69	23.40	5.36	0.49	1.46	0.00	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	30.25	25.79	5.95	0.00	0.99	0.50	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	30.96	23.46	4.69	0.47	1.41	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	40.07	30.47	6.29	0.00	1.32	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	40.83	25.68	8.66	1.24	2.17	0.00	0.00	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	42.50	30.27	7.64	0.31	1.53	0.00	0.00	0.61
Adipocyte - breast, donor1	11376-118A8	24.23	27.40	8.39	0.79	0.95	0.16	0.00	0.32
Adipocyte - breast, donor2	11327-117E4	18.93	23.26	7.38	1.44	0.16	0.00	0.00	0.32
Adipocyte - omental, donor1	11473-119C6	23.79	24.55	4.20	1.15	0.13	0.00	0.00	1.02
Adipocyte - omental, donor2	11474-119C7	14.20	21.68	4.48	0.00	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	17.75	19.09	4.35	0.00	0.00	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	22.97	15.31	6.38	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	21.99	8.80	2.20	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	22.58	10.39	3.61	0.45	0.45	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	11.64	17.90	2.95	0.17	0.70	0.00	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	30.51	25.23	4.69	0.98	0.20	0.20	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	22.91	9.52	2.57	0.26	0.26	0.51	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	28.16	22.86	6.97	0.56	0.28	0.28	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	19.99	20.57	7.05	0.59	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	25.58	30.65	6.84	0.72	0.24	0.00	0.00	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	31.31	28.40	5.16	0.32	1.29	0.32	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	18.66	29.33	5.87	0.53	1.07	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	11.69	22.26	3.34	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	12.48	23.71	3.74	0.42	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	28.38	26.37	6.03	1.00	0.25	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	15.71	19.63	5.24	0.00	0.00	0.00	0.00	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	10.96	16.14	4.26	0.00	0.61	0.00	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	36.46	6.19	2.21	0.44	0.00	0.00	0.00	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	8.96	1.08	0.36	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	10.78	1.20	1.20	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	13.31	3.06	1.26	0.36	0.00	0.18	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	0.00	1.67	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	12.53	3.90	2.05	0.21	0.00	0.00	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	24.49	9.61	4.35	0.00	0.00	0.00	0.00	0.34
Anulus Pulposus Cell, donor2	11463-119B5	13.71	8.57	1.47	0.00	0.00	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	45.83	105.58	8.54	3.59	2.25	0.00	1.80	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	48.19	128.07	13.02	3.04	1.30	0.43	0.43	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	74.91	119.85	8.56	2.14	2.14	2.14	2.14	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	38.56	94.76	11.36	2.09	2.39	1.49	0.90	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	46.79	106.23	11.38	0.00	1.26	0.00	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	39.60	64.69	16.50	3.30	2.64	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	34.44	82.52	14.62	2.92	2.27	0.32	0.00	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	49.03	98.06	11.17	1.46	0.49	0.00	0.49	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	32.66	77.80	18.41	1.19	1.19	1.19	0.59	2.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	43.69	90.39	13.94	2.64	1.13	0.75	0.75	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	38.46	95.79	15.96	5.81	1.45	0.73	0.00	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	35.11	66.45	12.54	0.00	2.51	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	65.73	108.40	23.56	3.46	0.99	0.99	0.66	3.29
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	40.94	126.93	21.84	0.00	2.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	46.29	88.67	17.04	1.51	1.51	0.60	0.90	1.51
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	47.15	107.16	14.47	2.14	1.61	0.54	0.54	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	55.36	94.85	14.93	3.21	0.94	0.94	0.57	2.08
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	45.17	86.87	14.17	1.87	1.60	0.53	1.07	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	51.70	130.71	13.66	1.95	3.90	6.83	1.95	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	50.26	91.89	13.77	3.15	0.66	0.17	0.66	1.49
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	43.23	91.25	18.01	2.40	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	74.34	169.93	14.16	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	47.17	94.68	14.58	2.57	1.03	0.86	0.86	1.72
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	88.09	12.58	0.00	8.39	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	44.66	126.70	16.50	1.46	0.97	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	56.16	124.84	14.04	1.52	2.28	0.00	1.90	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	48.45	101.75	8.48	0.00	2.42	1.21	1.21	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	39.90	103.75	16.53	2.85	0.00	0.00	2.85	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	44.47	98.12	13.04	3.21	2.57	0.43	0.43	1.50
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	40.26	75.88	17.81	2.06	1.55	0.52	0.26	2.84
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	53.02	102.76	14.55	1.88	0.94	0.00	1.41	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	46.30	95.50	18.65	3.54	1.61	0.96	0.32	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	34.25	82.76	12.13	2.14	1.43	1.43	0.71	3.57
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	50.31	98.27	12.87	1.17	2.34	0.00	0.58	2.34
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	44.86	96.64	18.37	2.41	2.41	0.60	1.20	1.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	38.02	58.21	8.32	2.38	1.19	1.19	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	47.80	104.76	14.24	2.03	1.53	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	46.86	102.64	12.73	2.04	2.55	0.76	0.51	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	34.95	80.69	15.25	3.18	3.81	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	42.29	97.53	15.97	1.29	3.45	0.43	1.29	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	42.55	92.93	13.55	2.75	1.06	0.42	0.42	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	39.44	71.05	11.60	2.32	1.74	0.29	0.58	2.32
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	59.52	99.20	17.95	1.89	4.72	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	48.31	91.54	12.88	2.54	2.20	0.85	0.34	1.02
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	37.06	55.59	13.90	2.32	0.00	2.32	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	48.59	158.44	21.13	0.00	4.23	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	49.96	97.56	12.01	2.36	2.14	0.64	0.00	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	43.92	96.27	14.44	1.20	0.60	0.00	2.41	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	45.93	131.22	21.87	2.19	0.73	0.00	1.46	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	54.48	108.27	14.94	4.60	1.15	0.46	2.53	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	99.46	17.85	0.00	0.00	0.00	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	46.52	100.42	13.47	2.80	2.80	0.51	1.02	1.78
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	48.10	115.61	15.07	2.27	2.68	0.00	0.21	1.45
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	45.59	83.84	13.77	1.84	2.14	0.31	0.61	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	43.02	120.94	15.30	2.87	2.87	0.00	2.39	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	42.80	103.77	13.08	1.77	2.00	0.22	0.44	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	39.67	82.39	21.36	0.00	3.05	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	37.66	101.36	13.29	3.88	1.66	0.00	1.11	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	42.63	95.59	13.50	2.38	3.71	0.00	0.53	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	34.53	78.50	13.45	1.09	0.73	0.36	0.73	1.09
Astrocyte - cerebellum, donor1	11500-119F6	21.49	4.91	1.23	0.25	0.00	0.12	0.00	0.12
Astrocyte - cerebellum, donor2	11580-120F5	12.49	2.40	1.03	0.00	0.00	0.00	0.00	0.17
Astrocyte - cerebellum, donor3	11661-122F5	7.76	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	47.41	8.37	2.44	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	46.27	4.85	2.10	0.00	0.00	0.00	0.00	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	45.05	5.22	4.18	0.45	0.30	0.00	0.00	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	75.35	6.65	4.47	1.83	0.00	0.00	0.00	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	75.29	9.27	5.26	1.88	0.00	0.00	0.00	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	67.82	4.89	4.44	0.68	0.00	0.00	0.00	0.80
Basophils, donor1	12241-129G9	34.26	16.48	3.14	0.26	0.26	0.26	0.00	0.26
Basophils, donor2	12242-129H1	24.53	11.18	3.25	1.44	0.00	0.36	0.00	0.00
Basophils, donor3	12243-129H2	35.43	21.76	4.85	2.94	0.15	0.00	0.00	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	13.80	3.23	2.16	0.43	0.22	0.00	0.00	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	4.11	1.37	0.91	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	21.97	7.53	1.88	0.00	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	16.84	4.16	2.29	0.00	0.00	0.00	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	18.42	8.75	2.07	0.23	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	32.03	5.94	1.98	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	67.30	5.36	3.81	0.21	0.00	0.00	0.00	0.93
Burkitt's lymphoma cell line:RAJI	10476-106I8	89.67	11.18	4.43	0.93	0.00	0.23	0.00	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	55.96	2.88	0.64	0.00	0.00	0.32	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	31.03	10.34	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	36.63	23.67	2.82	7.89	0.56	0.00	0.00	2.25
CD14+ Monocytes, donor2	11305-117B9	37.49	20.97	4.45	7.05	1.11	0.19	0.19	0.74
CD14+ Monocytes, donor3	11381-118B4	34.03	12.95	1.98	4.17	1.76	0.22	0.00	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	46.14	16.98	9.34	0.85	0.28	0.00	0.00	1.98
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	42.46	21.99	10.99	1.90	0.00	0.00	0.00	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	48.98	27.61	9.20	1.97	0.33	0.00	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	47.85	41.49	10.41	3.18	0.29	0.14	0.00	1.16
CD14+ monocytes - mock treated, donor2	11873-125C1	58.54	63.67	14.79	3.32	1.51	0.30	0.00	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	56.85	50.70	8.53	2.84	0.71	0.47	0.47	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	34.15	29.80	7.20	3.68	0.33	0.00	0.00	1.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	71.21	64.86	10.49	2.48	0.28	0.55	0.28	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	55.54	53.55	13.39	5.95	0.74	0.50	0.00	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	109.26	156.64	21.34	8.81	2.15	0.59	0.39	3.52
CD14+ monocytes - treated with BCG, donor2	11870-125B7	127.66	138.70	22.08	9.79	2.67	0.53	0.36	1.60
CD14+ monocytes - treated with BCG, donor3	11880-125C8	164.31	220.02	27.86	4.57	2.18	0.00	0.22	3.48
CD14+ monocytes - treated with Candida, donor1	11868-125B5	22.01	21.07	5.38	0.94	0.23	0.00	0.00	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	40.13	34.32	8.45	2.11	1.06	0.53	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	28.84	32.17	6.66	6.66	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	50.28	51.91	11.45	3.72	0.15	0.00	0.00	1.19
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	79.82	93.59	11.37	3.99	0.80	0.60	0.00	1.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	68.50	88.07	14.16	2.50	0.42	0.21	0.00	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	41.87	37.52	9.84	1.14	0.00	0.00	0.00	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	71.71	77.81	11.99	0.23	0.90	0.00	0.00	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	42.34	48.45	6.11	2.18	0.87	0.00	0.00	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	95.22	164.89	28.24	5.38	3.77	1.08	0.27	3.50
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	156.14	203.77	30.01	10.64	3.49	1.40	0.52	1.74
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	127.93	201.57	31.98	5.47	2.52	1.68	0.42	2.52
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	37.48	29.03	5.88	2.02	0.00	0.18	0.00	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	63.41	46.85	8.81	1.06	0.00	0.70	0.00	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	49.58	44.75	6.14	0.88	0.88	0.88	0.00	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	128.51	125.90	21.27	11.86	2.62	0.35	0.52	1.39
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	133.80	121.54	16.73	7.43	3.35	0.00	0.37	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	154.12	195.72	23.06	6.90	1.94	0.43	0.65	3.02
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	24.57	18.02	6.55	2.05	0.00	0.41	0.00	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	47.98	45.66	5.79	0.70	0.00	0.00	0.00	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	45.24	33.41	6.96	1.16	0.23	0.00	0.00	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	24.85	6.32	3.27	0.44	0.00	0.00	0.00	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	23.10	6.93	4.16	1.85	0.23	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	29.03	3.25	2.38	0.65	0.65	0.22	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	33.48	6.23	3.11	2.80	0.00	0.00	0.00	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	24.45	6.29	2.79	0.87	0.00	0.00	0.00	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	26.98	5.35	2.23	0.45	0.00	0.00	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	21.95	4.34	4.08	1.28	0.00	0.00	0.00	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	24.59	3.95	3.07	0.66	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	28.21	3.16	1.47	0.42	0.21	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	46.74	2.03	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	54.92	0.00	0.68	0.68	0.00	0.00	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	61.10	1.04	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	61.30	5.86	2.67	1.07	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	62.18	2.14	3.22	0.54	0.00	0.00	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	48.43	0.70	0.70	0.00	0.00	0.00	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	63.53	1.57	0.78	0.00	0.00	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	59.32	2.64	2.64	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	46.85	6.58	4.11	4.11	1.64	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	62.39	14.51	4.35	4.35	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	41.90	6.06	2.52	3.03	0.00	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	33.54	1.62	2.02	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	27.96	1.20	1.20	0.40	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	30.12	12.05	0.00	2.01	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	60.68	55.62	8.43	4.49	0.00	4.49	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	45.09	0.00	0.75	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	38.56	2.48	0.90	0.23	0.00	0.00	0.00	0.68
CD4+ T Cells, donor1	11225-116C1	61.77	17.85	8.57	10.35	0.36	0.00	0.00	1.07
CD4+ T Cells, donor2	11306-117C1	62.46	12.86	6.74	5.51	0.00	0.61	0.00	1.22
CD4+ T Cells, donor3	11382-118B5	43.61	10.37	4.88	0.91	0.00	0.00	0.00	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	48.24	7.15	2.30	1.53	0.00	0.00	0.00	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	47.84	4.04	3.14	0.90	0.00	0.00	0.00	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	49.16	4.89	4.89	1.72	0.00	0.00	0.00	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	79.65	10.43	7.11	2.37	0.00	0.00	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	87.09	9.83	7.73	2.11	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	49.44	3.30	3.30	3.30	0.00	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	36.27	8.96	4.19	0.29	0.14	0.00	0.00	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	34.74	6.27	4.91	0.85	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	29.18	6.13	4.51	1.13	0.00	0.00	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	50.21	3.14	2.69	2.24	0.00	0.00	0.00	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	51.71	6.99	5.24	1.40	0.00	0.00	0.00	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	44.88	4.84	2.64	0.00	0.00	0.00	0.00	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	40.06	16.02	5.48	0.84	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	37.61	9.56	6.86	1.04	0.21	0.00	0.00	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	38.09	10.69	6.35	0.67	0.00	0.00	0.00	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	55.20	6.80	3.54	2.72	0.00	0.00	0.00	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	65.39	13.93	5.90	3.22	0.54	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	55.59	7.17	3.59	1.79	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	45.99	11.68	4.82	0.56	0.00	0.00	0.00	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	37.69	6.72	4.98	0.43	0.00	0.00	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	32.15	8.20	4.83	0.63	0.00	0.00	0.00	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	60.17	5.06	6.57	3.03	0.00	0.00	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	55.02	6.50	4.77	1.73	0.00	0.00	0.00	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	49.25	5.67	2.61	0.44	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	77.69	10.39	4.45	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	60.93	1.85	6.46	0.92	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	69.79	2.79	2.79	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	80.59	9.69	5.54	2.77	0.00	0.00	0.00	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	67.48	9.82	3.68	0.25	0.25	0.00	0.00	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	66.22	6.16	9.24	1.54	0.00	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	64.46	8.24	3.94	0.72	0.00	0.00	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	92.79	11.08	5.54	0.00	0.00	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	41.91	10.15	2.29	5.24	0.33	0.00	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	34.16	7.13	2.25	5.63	0.38	0.00	0.00	0.75
CD8+ T Cells, donor3	11383-118B6	50.50	8.58	3.28	4.04	0.00	0.00	0.25	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	24.09	1.15	0.69	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	25.88	1.92	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	24.35	0.82	0.55	0.27	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	36.03	2.70	1.20	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	25.92	1.44	0.00	0.00	0.00	0.00	0.00	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	32.97	1.59	0.45	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	26.73	0.65	0.65	0.43	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	24.48	1.58	0.79	0.26	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	28.61	0.23	1.64	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	24.75	0.91	0.30	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	28.76	2.61	1.16	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	29.04	2.40	0.80	0.27	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	27.14	5.25	0.88	0.00	1.31	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	29.15	6.83	1.82	0.46	0.46	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	24.61	8.95	1.49	0.75	0.75	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	32.41	1.44	1.80	0.00	0.36	0.00	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	34.53	1.44	0.29	0.00	0.00	0.29	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	28.52	1.18	0.47	0.47	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	24.40	0.95	1.27	0.00	0.00	0.32	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	29.53	1.23	0.31	0.31	0.31	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	29.49	1.60	0.64	0.32	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	28.30	2.29	0.00	0.38	0.38	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	25.62	0.79	0.79	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	29.50	0.00	0.76	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	36.94	8.83	0.00	0.00	0.80	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	48.26	6.29	3.50	0.70	2.10	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	39.07	19.03	6.01	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	27.42	23.76	9.14	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	10.38	7.41	2.47	0.49	0.00	0.00	0.00	0.99
Cardiac Myocyte, donor3	11686-122I3	34.31	17.15	4.63	0.95	0.74	0.11	0.00	0.32
Chondrocyte - de diff, donor1	11261-116G1	30.85	12.13	4.16	0.00	0.00	0.35	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	19.55	6.40	0.71	1.07	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	20.25	9.90	3.30	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	45.66	12.53	3.58	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	21.43	1.21	0.81	0.81	0.00	0.00	0.00	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	49.46	6.08	1.95	0.69	0.00	0.23	0.00	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	37.62	4.06	1.71	1.28	0.00	0.00	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	39.65	4.25	2.21	0.53	0.00	0.00	0.00	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	30.17	9.45	2.29	1.01	0.09	0.64	0.00	0.28
Corneal Epithelial Cells, donor1	11526-119I5	13.17	1.54	0.88	0.22	0.00	0.00	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	10.24	3.41	1.14	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	16.62	4.60	1.28	0.51	0.26	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	25.42	1.98	1.16	0.00	0.00	0.00	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	26.18	1.89	1.58	0.32	0.32	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	6.90	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	28.73	4.10	1.73	0.00	0.11	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	42.36	11.62	2.39	3.76	0.00	0.34	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	49.62	15.67	3.92	3.92	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	55.17	21.78	5.81	6.78	0.00	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	79.72	93.39	15.51	3.50	3.00	5.50	0.83	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	51.05	60.44	6.45	4.11	0.59	2.35	0.59	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	89.93	102.37	15.84	3.11	5.94	9.33	0.57	2.55
Endothelial Cells - Aortic, donor3	11412-118E8	47.97	58.19	8.65	2.36	2.36	5.50	1.97	1.97
Endothelial Cells - Artery, donor1	11264-116G4	45.96	66.90	6.11	2.62	3.20	4.07	1.16	0.58
Endothelial Cells - Artery, donor2	11341-117F9	69.41	76.70	13.88	1.88	0.94	5.41	1.41	1.65
Endothelial Cells - Artery, donor3	11413-118E9	76.26	71.53	15.25	1.93	2.10	4.03	0.70	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	61.40	26.82	6.43	2.88	1.11	5.32	0.44	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	64.50	40.47	8.82	3.35	1.22	8.22	0.30	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	106.00	63.43	6.20	3.10	0.56	14.66	0.56	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	62.99	74.28	10.70	4.16	2.08	4.75	0.30	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	56.23	22.91	4.17	1.04	0.00	1.56	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	50.19	38.14	6.66	2.69	1.13	4.40	0.14	1.42
Endothelial Cells - Thoracic, donor1	11266-116G6	115.63	172.85	20.41	4.80	3.60	8.80	0.80	2.80
Endothelial Cells - Thoracic, donor2	11343-117G2	50.84	78.62	6.29	2.62	4.72	1.57	0.52	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	166.61	103.62	22.86	6.34	2.98	13.17	0.12	2.61
Endothelial Cells - Umbilical vein, donor2	11324-117E1	108.63	63.44	14.12	3.48	3.91	14.77	0.22	1.52
Endothelial Cells - Umbilical vein, donor3	11400-118D5	122.98	69.49	13.80	2.56	2.44	12.58	0.12	1.10
Endothelial Cells - Vein, donor1	11267-116G7	44.36	39.81	9.10	0.00	2.28	5.69	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	47.50	27.24	4.19	0.00	0.70	2.79	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	101.58	78.97	14.60	2.83	2.36	8.64	0.00	1.26
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	26.40	11.55	1.65	0.00	0.00	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	17.83	10.70	3.57	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	13.68	1.95	1.95	0.00	0.00	0.00	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	8.32	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	21.76	32.02	6.16	0.00	1.23	0.00	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	29.34	75.98	9.31	0.66	3.18	0.33	2.30	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	39.33	72.15	13.00	0.43	2.71	0.54	0.11	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	89.63	123.58	20.98	1.33	0.85	0.49	0.97	1.58
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	98.53	123.78	24.97	18.01	5.60	1.23	3.28	1.91
Fibroblast - Aortic Adventitial, donor2	11326-117E3	49.89	83.11	15.08	1.05	1.48	0.32	0.42	1.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	35.83	65.35	12.38	4.74	2.37	0.26	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	66.11	79.73	15.28	0.66	0.66	0.33	1.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	22.68	16.78	3.18	0.45	0.45	0.45	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	38.66	55.33	8.34	0.76	1.52	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	40.69	58.04	10.09	1.10	1.58	0.32	0.63	0.63
Fibroblast - Cardiac, donor4	11452-119A3	39.71	35.16	5.46	2.12	0.30	0.30	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	101.02	194.16	27.16	6.35	3.93	1.02	0.76	1.90
Fibroblast - Cardiac, donor6	11460-119B2	78.53	152.20	23.50	5.91	2.27	1.36	0.45	0.91
Fibroblast - Choroid Plexus, donor1	11492-119E7	19.96	9.78	2.01	0.13	0.13	0.13	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	22.43	18.55	2.59	1.29	0.00	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	55.66	8.79	2.93	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	84.88	31.83	7.38	1.15	2.31	0.23	0.00	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	27.98	34.26	10.69	1.02	0.34	0.00	0.17	0.68
Fibroblast - Dermal, donor1	11269-116G9	36.16	26.77	4.23	0.23	0.23	0.23	0.00	0.94
Fibroblast - Dermal, donor2	11346-117G5	52.36	31.13	8.02	0.47	0.47	1.42	0.00	0.94
Fibroblast - Dermal, donor3	11418-118F5	36.75	30.71	6.65	0.97	0.24	0.36	0.00	0.60
Fibroblast - Dermal, donor4	11450-119A1	69.30	35.95	10.51	1.47	0.68	0.11	0.00	0.90
Fibroblast - Dermal, donor5	11454-119A5	71.70	49.37	13.43	1.05	0.00	0.35	0.00	0.35
Fibroblast - Dermal, donor6	11458-119A9	73.74	45.32	9.91	1.62	0.49	0.00	0.00	0.81
Fibroblast - Gingival, donor1	11237-116D4	32.90	27.07	6.25	0.62	0.00	0.00	0.00	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	30.13	36.42	7.86	0.52	0.00	0.00	0.00	0.79
Fibroblast - Gingival, donor2	11318-117D4	52.32	16.08	3.95	0.92	0.00	0.00	0.00	0.53
Fibroblast - Gingival, donor3	11394-118C8	33.45	32.10	8.90	0.68	0.58	0.10	0.00	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	17.66	33.24	7.27	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	17.80	17.27	3.70	0.35	0.35	0.00	0.00	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	29.31	33.67	8.42	0.47	0.16	0.00	0.00	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	17.44	33.40	8.25	0.54	0.00	0.00	0.00	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	8.47	7.76	2.12	0.00	1.06	0.00	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	22.81	30.42	8.04	0.58	0.29	0.00	0.00	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	21.54	37.77	6.95	0.68	0.14	0.00	0.00	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	26.44	32.69	7.35	0.55	0.11	0.00	0.11	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	18.49	29.05	6.60	0.44	1.17	0.00	0.00	0.44
Fibroblast - Lung, donor1	11270-116H1	8.16	4.08	2.72	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	34.32	8.95	5.97	0.00	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	24.06	10.76	3.38	0.21	0.21	0.00	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	18.33	11.66	3.33	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	9.79	2.80	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	4.76	5.88	2.52	0.00	0.56	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	51.96	20.70	5.68	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	0.00	3.99	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	11.91	11.91	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	74.87	27.93	11.44	0.58	0.00	0.19	0.19	1.36
Fibroblast - Periodontal Ligament, donor2	11319-117D5	79.94	27.45	11.98	1.52	0.46	0.00	0.00	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	50.49	48.96	9.49	1.53	0.61	0.61	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	20.23	32.82	4.20	0.38	0.76	0.00	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	21.60	29.97	7.83	1.62	0.27	0.27	0.00	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	14.26	13.45	4.18	0.35	0.46	0.12	0.00	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	107.66	157.07	30.18	1.66	1.88	0.22	0.66	1.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	22.96	14.02	3.45	0.61	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	20.71	6.01	2.00	0.00	0.00	1.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	28.86	17.00	3.95	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	25.20	19.84	3.97	1.98	0.00	0.20	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	28.60	21.85	4.26	0.36	0.00	0.00	0.00	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	30.75	24.44	5.32	0.59	0.39	0.00	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	25.27	18.65	5.11	1.81	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	42.10	42.32	6.37	1.19	0.11	0.11	0.11	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	20.75	18.98	5.57	2.02	0.00	0.25	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	22.97	20.51	4.27	0.16	0.00	0.00	0.00	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	25.46	21.65	6.62	3.61	0.00	0.20	0.00	0.60
Fibroblast - skin normal, donor2	11561-120D4	38.38	56.46	11.05	0.50	0.00	0.00	0.10	1.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	29.32	19.04	4.53	2.72	0.00	0.00	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	30.65	28.33	8.28	0.66	0.17	0.08	0.00	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	25.13	26.67	6.84	1.20	0.34	0.00	0.00	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	18.06	22.00	3.28	0.33	0.33	0.33	0.00	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	40.27	37.71	7.56	0.53	0.21	0.00	0.00	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	32.89	17.21	4.55	0.17	0.17	0.00	0.00	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	15.37	20.23	4.55	0.16	0.31	0.00	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	376.72	509.68	88.64	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	20.05	31.38	11.33	0.87	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	87.72	89.80	25.14	4.85	1.56	0.52	0.52	1.21
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	107.74	89.78	23.68	2.34	3.38	0.00	0.78	1.30
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	48.04	28.87	10.73	0.77	2.56	0.00	0.00	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	53.59	5.36	5.36	0.77	0.77	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	54.87	8.29	4.47	0.00	0.00	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	78.45	5.13	2.57	0.86	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	58.18	6.89	3.86	0.00	0.28	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	42.24	9.13	1.83	0.23	0.23	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	75.29	5.94	2.97	0.20	0.20	0.00	0.00	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	56.04	6.87	3.97	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	38.81	10.44	2.61	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	59.70	6.63	0.88	0.44	0.00	0.00	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	67.13	5.79	3.39	0.28	0.00	0.00	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	59.11	6.65	4.56	0.62	0.00	0.00	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	64.74	5.37	2.69	0.27	0.00	0.00	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	87.22	7.81	3.84	0.12	0.00	0.12	0.00	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	89.15	5.26	4.01	0.14	0.00	0.14	0.00	0.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	70.34	10.98	4.07	0.20	0.20	0.41	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	56.59	6.85	5.25	0.68	0.00	0.00	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	73.87	8.60	4.61	0.37	0.00	0.25	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	86.12	10.27	3.93	0.22	0.00	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	49.05	7.09	2.66	0.59	0.00	0.00	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	50.23	7.79	2.70	0.32	0.00	0.00	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	57.87	6.03	2.68	0.22	0.00	0.00	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	43.55	6.05	1.61	0.40	0.00	0.00	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	50.04	8.99	2.71	0.17	0.00	0.00	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	63.13	12.06	5.50	0.35	0.18	0.09	0.09	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	37.77	5.62	1.98	0.42	0.00	0.10	0.00	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.79	5.98	2.05	0.00	0.00	0.00	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	44.48	7.08	1.99	0.55	0.00	0.00	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	59.40	11.40	3.66	0.75	0.08	0.08	0.00	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	53.70	10.82	3.06	0.41	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	42.71	7.63	1.65	0.00	0.00	0.00	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	42.54	6.57	2.54	0.35	0.00	0.00	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	39.02	8.67	3.34	0.83	0.17	0.00	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	40.56	4.41	4.19	0.22	0.00	0.00	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	42.06	6.76	2.21	0.12	0.00	0.00	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	48.95	5.51	2.43	0.97	0.16	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	41.37	6.41	3.21	0.00	0.00	0.00	0.00	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	37.33	5.50	2.27	0.28	0.19	0.00	0.00	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	32.74	4.75	2.53	0.00	0.00	0.16	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	36.19	6.08	1.82	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	38.47	6.27	1.99	0.42	0.00	0.00	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	37.76	7.68	1.32	0.00	0.22	0.00	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	39.00	4.77	1.96	0.28	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	32.41	11.02	3.80	0.28	0.00	0.28	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	37.97	5.62	2.41	0.53	0.27	0.00	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	39.93	8.57	3.52	0.15	0.00	0.15	0.00	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	34.07	10.36	4.15	0.13	0.26	0.00	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	32.26	6.23	3.80	0.00	0.27	0.00	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	35.21	9.40	4.06	0.37	0.00	0.18	0.00	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	32.24	9.65	3.73	0.22	0.22	0.22	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	26.78	9.92	4.96	0.99	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	34.03	12.27	3.56	0.40	0.13	0.13	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	30.06	10.69	3.03	0.40	0.00	0.20	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	29.23	8.13	2.54	0.00	0.00	0.00	0.00	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	109.88	10.15	4.38	0.40	0.00	0.00	0.00	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	78.42	4.62	2.47	0.15	0.00	0.00	0.00	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	83.27	5.73	2.86	0.82	0.20	0.00	0.00	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	73.23	5.63	5.32	0.31	0.00	0.00	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	67.81	6.78	3.96	0.00	0.00	0.00	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	77.02	7.84	4.15	0.46	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	69.29	17.32	7.42	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	74.27	12.38	4.25	0.39	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	73.81	9.63	6.42	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	67.81	6.96	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	54.03	8.14	3.91	0.00	0.33	0.00	0.00	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	51.89	10.30	2.47	0.82	1.24	0.00	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	49.98	10.00	6.66	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	53.13	9.79	1.96	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	58.50	10.79	3.92	0.00	0.33	0.33	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	34.39	6.71	1.68	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	56.62	9.54	3.18	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	56.04	11.55	4.42	0.34	0.34	0.00	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	64.73	6.26	0.00	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	71.01	5.73	4.01	0.00	0.00	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	50.32	5.62	2.37	0.00	0.00	0.59	0.00	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	37.27	18.64	1.69	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	55.92	11.18	2.07	0.41	0.00	0.83	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	50.40	9.90	3.68	0.46	0.00	0.92	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	43.82	9.23	2.31	0.00	0.00	0.38	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	41.72	7.17	3.59	0.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	53.51	5.35	6.02	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	62.03	8.09	2.31	0.77	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	58.54	13.01	1.71	1.03	0.00	1.37	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	64.60	4.97	2.48	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	58.04	5.66	2.36	0.47	0.47	0.47	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	52.50	3.62	1.21	0.60	0.00	0.00	0.00	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	53.41	5.60	2.03	0.00	0.00	0.00	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	45.07	7.58	3.19	0.00	0.00	0.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	59.20	4.93	2.47	0.00	0.00	0.00	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	60.20	9.44	2.36	2.36	0.00	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	58.34	8.17	2.33	0.00	0.00	0.00	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	54.86	8.34	2.63	0.88	0.44	0.88	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	43.23	1.70	5.09	0.85	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	30.44	7.16	2.98	1.19	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	29.60	7.76	1.46	0.49	0.00	0.00	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	7.99	10.27	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	13.31	14.55	2.91	0.42	0.00	0.00	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	3.37	3.37	2.25	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	12.05	13.32	1.90	0.00	1.27	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	7.94	13.37	1.25	0.42	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	48.51	11.14	3.95	0.12	0.00	0.00	0.00	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	50.47	10.30	2.19	0.34	0.00	0.00	0.00	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	42.77	7.74	2.28	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	45.91	11.70	5.25	0.22	0.11	0.11	0.00	0.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	47.93	11.18	3.01	0.21	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	46.07	12.27	1.94	0.22	0.00	0.00	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	42.59	9.34	3.11	0.12	0.00	0.00	0.00	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	39.97	8.92	3.77	0.34	0.17	0.00	0.00	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	40.05	9.29	3.84	0.64	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	49.81	51.49	6.16	0.56	2.24	9.51	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	37.65	21.64	5.19	0.87	0.43	2.16	0.00	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	74.03	60.81	21.15	0.00	2.64	2.64	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	16.23	7.76	3.53	0.71	0.00	0.00	0.00	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	8.72	7.99	1.45	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	78.85	98.43	14.69	2.45	0.87	0.00	0.17	1.05
Hepatocyte, donor1	11523-119I2	24.21	0.00	1.21	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	28.01	2.15	0.00	1.08	0.00	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	26.38	6.75	0.61	0.00	0.00	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	36.55	7.18	2.61	0.65	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	64.67	8.04	2.45	1.22	0.00	0.00	0.00	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	33.20	9.74	3.16	0.14	0.00	0.00	0.00	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	3.18	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	6.92	1.38	1.38	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	2.50	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	0.00	5.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	9.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	6.50	1.62	1.62	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	20.01	3.33	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	7.26	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	13.23	1.32	1.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	21.06	2.22	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	15.75	1.26	0.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	15.47	1.55	0.00	1.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	18.09	3.23	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	6.44	1.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	17.93	1.63	3.26	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	13.01	1.26	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	19.29	0.80	0.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	21.24	0.00	0.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	15.11	2.83	0.94	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	12.70	1.81	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	14.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	16.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	17.79	2.54	1.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	12.75	0.64	1.28	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	12.85	0.71	1.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	12.66	3.40	0.93	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	8.78	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	9.74	0.00	0.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	3.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	9.59	2.62	0.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	6.75	2.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	12.80	4.27	2.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	2.77	1.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	0.00	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	11.05	0.92	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	9.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	6.21	12.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	11.63	8.46	3.17	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	41.21	24.32	9.96	0.57	0.49	0.41	0.00	0.65
Keratinocyte - epidermal, donor2	11349-117G8	15.81	6.44	2.34	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	62.19	18.36	9.18	0.00	0.09	0.09	0.00	0.76
Keratinocyte - oral, donor1	11251-116E9	66.07	12.37	5.56	0.57	0.23	0.00	0.00	0.91
Keratocytes, donor1	11527-119I6	89.74	31.98	7.91	1.72	0.69	0.34	0.00	1.38
Keratocytes, donor2	11607-120I5	23.44	5.86	3.52	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	55.13	43.08	9.09	0.40	0.79	0.20	0.40	1.19
Krukenberg tumor cell line:HSKTC	10687-109F3	46.16	6.59	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	40.99	5.39	3.24	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	52.13	4.15	1.61	0.12	0.00	0.00	0.00	0.35
Lens Epithelial Cells, donor3	11690-122I7	22.70	7.16	2.72	0.10	0.10	0.00	0.00	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	107.43	69.72	12.45	3.08	1.90	7.11	0.71	1.90
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	64.19	53.02	12.00	3.35	0.56	5.30	0.28	2.23
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	94.60	71.62	13.85	5.51	1.26	5.67	1.10	1.73
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	75.82	61.84	4.84	3.76	1.08	5.38	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	62.72	41.60	10.40	1.89	1.58	7.88	0.00	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	57.57	34.39	5.93	1.73	1.08	4.31	0.32	0.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	88.64	62.38	11.90	3.28	1.64	4.10	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	47.78	34.64	8.60	2.02	0.25	3.79	0.25	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	55.31	39.83	8.02	3.66	0.84	3.94	0.28	0.99
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	76.73	64.87	13.45	1.58	1.19	5.14	0.00	1.98
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	84.53	78.91	14.74	3.30	0.97	3.88	0.39	2.33
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	36.66	26.48	6.11	2.22	0.56	2.59	0.19	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	67.94	61.67	8.01	0.70	1.74	3.48	1.39	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	67.50	62.02	14.31	2.39	0.72	4.29	0.48	2.15
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	54.25	34.89	8.10	3.16	0.82	4.40	0.55	1.51
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	84.07	79.45	11.09	2.16	0.31	4.62	0.31	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	38.97	37.72	7.17	0.62	0.94	1.56	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	50.32	38.61	6.40	1.10	1.10	3.29	0.18	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	77.01	61.54	10.53	0.99	0.99	3.62	0.00	1.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	41.88	33.97	5.56	2.34	0.29	2.93	0.00	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	35.60	26.88	5.97	2.49	0.50	2.49	0.50	1.74
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	79.53	81.96	10.67	3.88	1.45	4.85	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	64.90	65.98	12.12	3.23	1.08	4.31	1.62	2.42
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	63.88	51.32	9.84	2.12	0.76	4.54	0.45	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	61.69	57.54	11.92	1.56	3.11	2.59	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	92.13	88.15	17.17	3.98	1.47	5.44	0.21	1.47
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	55.94	44.21	7.22	2.11	1.50	4.66	0.90	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	78.42	82.55	10.32	2.75	3.44	6.88	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	84.48	69.05	13.73	1.69	0.75	4.52	0.38	2.63
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	42.09	34.46	5.20	2.23	0.53	3.82	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	86.74	82.38	13.57	4.36	1.45	5.33	0.97	1.94
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	58.22	52.26	12.24	2.32	0.66	2.65	0.00	2.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	44.48	34.94	4.83	2.73	0.62	3.22	0.37	1.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	104.40	108.47	15.55	7.03	2.96	7.77	0.37	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	74.12	73.88	12.35	2.72	0.49	3.46	0.74	1.73
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	43.72	29.84	5.50	1.79	0.82	3.57	0.41	1.10
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	84.91	72.05	13.51	3.54	1.93	6.43	0.00	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	82.78	85.52	15.22	2.74	0.91	5.48	0.91	3.04
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	89.86	75.44	12.32	3.78	1.12	4.76	0.98	1.96
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	96.00	82.85	16.71	3.20	2.84	6.04	0.36	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	45.57	37.33	9.21	0.48	0.97	2.91	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	36.72	26.14	4.51	3.58	0.78	3.73	0.00	1.40
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	94.54	74.13	13.97	3.58	1.43	2.15	0.72	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	71.87	62.39	12.74	2.29	1.63	4.25	0.33	3.92
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	33.90	25.19	3.06	2.12	0.24	3.77	0.24	1.41
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	125.98	89.35	15.72	1.61	1.61	7.67	0.74	1.86
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	51.23	43.29	8.20	1.28	0.77	4.35	0.26	1.28
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	54.90	39.98	5.37	0.90	0.90	2.98	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	2.27	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	13.81	7.67	1.53	1.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	14.10	2.97	1.48	0.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	8.89	3.39	1.69	0.85	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	14.77	4.22	1.41	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	16.81	1.87	1.87	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	9.79	5.15	1.03	0.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	15.46	1.19	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	12.89	2.94	3.39	0.68	0.00	0.00	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	17.16	6.11	1.16	0.00	0.00	0.00	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	20.26	8.10	2.25	0.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	19.65	4.61	1.63	0.54	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	16.95	3.08	3.08	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	21.52	5.65	1.41	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	21.99	4.66	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	15.79	3.57	1.53	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	23.21	6.94	3.47	0.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	22.86	7.56	1.51	0.57	0.00	0.00	0.00	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	18.41	4.29	1.84	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	18.75	7.34	0.82	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	21.87	6.66	1.67	0.83	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	22.70	8.69	2.52	0.28	0.00	0.00	0.00	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	20.61	2.06	1.03	0.00	0.00	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	23.22	5.52	1.45	1.45	0.00	0.00	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	24.21	5.98	1.49	0.00	0.00	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	30.43	6.09	1.11	0.00	0.55	0.00	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	17.67	5.30	1.77	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	13.28	4.43	2.21	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	14.97	2.30	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	13.82	7.68	1.54	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	11.89	2.83	2.26	1.13	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	18.87	4.92	0.82	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	15.82	4.52	0.45	0.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.95	5.03	0.72	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	26.89	2.24	2.24	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	14.86	3.72	2.60	0.37	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	23.26	3.88	1.29	0.00	0.00	0.00	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	15.41	2.57	1.71	0.00	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	13.33	4.33	1.33	1.67	0.33	0.00	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	16.29	1.81	1.81	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.22	4.27	0.71	1.42	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	18.56	5.84	1.03	0.69	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	10.20	3.22	0.54	1.07	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	17.51	4.71	0.67	0.00	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	12.96	5.19	1.48	0.74	0.00	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	20.93	6.98	1.16	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	12.69	4.23	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	12.80	2.40	1.60	0.80	0.00	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	6.54	2.91	0.73	0.73	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	14.56	3.83	0.77	1.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.80	1.97	0.99	0.99	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16.00	3.76	3.76	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	17.60	3.02	1.51	0.50	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	16.67	1.35	0.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	3.44	3.44	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	14.70	3.56	1.78	0.00	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	15.64	3.52	2.35	1.17	0.00	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	15.17	2.64	0.66	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	9.34	6.23	1.04	0.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	16.19	4.38	0.88	1.75	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	14.54	3.35	1.68	0.56	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	18.99	4.86	0.44	0.88	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	12.73	4.63	1.54	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	14.68	5.06	1.01	1.01	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	22.11	2.40	0.48	1.92	0.00	0.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	17.89	3.58	1.59	0.40	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	23.09	3.04	0.61	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	11.07	6.92	0.00	0.69	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	14.44	3.42	0.76	0.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	16.53	2.58	2.58	0.00	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	15.72	5.44	1.21	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	20.28	1.90	0.95	0.95	0.00	0.00	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	11.73	2.13	1.07	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	9.77	4.02	1.72	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	18.00	3.09	0.51	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	19.81	2.83	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	14.19	5.67	0.57	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	15.81	1.25	1.25	0.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	14.09	3.13	0.00	0.78	0.00	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	14.61	3.76	1.25	0.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	13.47	2.79	2.32	0.46	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	10.04	4.01	0.67	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	20.85	8.02	0.53	0.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	13.74	3.23	1.62	1.62	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	15.60	1.84	0.92	0.92	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.00	3.56	0.00	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	17.67	2.85	1.14	0.00	0.00	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	12.27	7.67	0.77	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	22.43	5.47	2.19	0.00	0.00	0.00	0.00	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	13.36	4.01	1.78	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	15.86	3.90	1.56	0.52	0.00	0.00	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	23.21	5.97	0.66	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	24.94	4.16	2.08	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	39.43	39.89	14.59	1.14	0.68	0.00	0.00	0.91
Macrophage - monocyte derived, donor2	11313-117C8	85.33	14.50	2.75	3.30	0.37	0.00	0.00	0.37
Macrophage - monocyte derived, donor3	11389-118C3	52.17	28.31	7.47	0.26	0.52	0.00	0.00	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	122.67	109.92	30.80	3.19	3.72	0.53	0.53	2.12
Mallassez-derived cells, donor2	11929-125I3	172.55	270.64	46.27	3.49	6.18	0.95	5.39	1.90
Mallassez-derived cells, donor3	11930-125I4	112.16	99.24	28.21	1.67	2.08	0.69	1.25	1.81
Mammary Epithelial Cell, donor1	11273-116H4	64.57	38.66	14.35	1.20	0.60	0.00	0.10	0.90
Mammary Epithelial Cell, donor2	11350-117G9	51.54	21.14	8.11	0.87	0.29	0.00	0.00	1.16
Mammary Epithelial Cell, donor3	11422-118F9	25.94	6.98	2.74	0.25	0.00	0.25	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	21.02	16.27	4.07	0.00	0.00	0.00	0.00	1.36
Mast cell, donor1	11563-120D6	25.30	4.87	2.16	0.43	0.00	0.00	0.00	0.11
Mast cell, donor2	11565-120D8	26.75	10.70	1.49	1.78	0.00	1.19	0.00	0.30
Mast cell, donor3	11566-120D9	31.74	6.53	1.80	0.68	0.45	1.80	0.00	0.45
Mast cell, donor4	11567-120E1	30.49	12.76	4.43	0.89	0.18	0.53	0.00	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	34.60	4.66	1.89	0.55	0.00	0.00	0.00	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	35.02	3.50	2.33	0.58	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	31.66	5.05	2.29	0.11	0.00	0.00	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	38.16	10.04	3.35	0.84	0.00	0.17	0.00	0.50
Melanocyte - dark, donor1	11502-119F8	112.33	11.44	3.18	1.49	0.50	7.06	0.00	0.70
Melanocyte - dark, donor2	11582-120F7	15.57	8.31	2.77	1.04	0.00	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	47.59	11.95	4.78	0.58	0.00	0.00	0.00	0.43
Melanocyte - light, donor1	11274-116H5	9.87	2.82	0.71	0.24	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	10.24	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	13.01	5.20	0.87	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	30.72	6.77	2.29	0.31	0.00	0.00	0.00	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	29.05	5.11	1.88	0.27	0.00	0.00	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	31.07	4.82	2.95	0.27	0.00	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	45.16	16.75	3.35	0.62	0.12	0.00	0.12	0.37
Meningeal Cells, donor2	11573-120E7	42.25	21.13	3.96	0.44	0.00	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	54.85	21.60	8.48	0.41	0.08	0.08	0.00	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	37.64	8.84	2.85	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	61.99	47.90	9.26	2.01	1.01	0.10	0.50	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	2.63	1.31	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	2.62	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	31.57	28.70	7.18	0.00	0.00	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	21.18	15.25	1.91	0.85	0.21	0.00	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	17.59	21.61	3.02	0.00	0.50	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	21.54	3.08	0.44	0.22	0.22	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	16.80	4.38	1.46	0.73	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	12.48	4.09	1.23	0.00	0.00	0.20	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	19.53	11.08	3.60	0.28	0.14	0.00	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.95	4.46	0.37	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	29.47	20.13	5.13	0.39	0.00	0.13	0.00	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	4.15	3.86	1.19	0.00	0.00	0.00	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	15.37	4.48	1.28	0.00	0.00	0.00	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	49.62	32.25	11.34	1.06	0.35	0.71	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	28.15	19.39	5.00	0.00	0.00	0.00	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	30.48	7.26	3.63	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	37.65	49.59	10.87	1.86	2.12	0.00	0.80	0.27
Mesothelial Cells, donor2	12156-128G5	37.03	37.53	11.51	2.50	2.50	0.00	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	24.43	24.57	6.79	0.65	0.65	0.14	0.07	0.43
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	37.81	10.80	0.00	0.00	1.35	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	53.93	20.69	5.17	0.00	0.25	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	49.47	15.90	2.94	0.29	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	3.46	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	40.60	15.50	3.41	0.93	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	38.38	14.73	3.73	0.83	0.00	0.00	0.21	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	11.58	0.00	2.32	0.00	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	53.81	19.52	2.50	0.75	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	38.63	14.43	3.26	1.40	0.47	0.00	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	42.07	16.46	3.05	0.61	0.00	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	39.60	11.88	5.15	0.79	0.40	0.00	0.00	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	17.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	23.89	19.47	4.42	0.88	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	45.59	17.86	2.66	0.38	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	13.16	17.11	2.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	36.93	18.89	4.46	1.49	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	17.50	5.52	0.92	0.92	0.92	0.00	0.00	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	30.70	22.35	3.87	0.60	0.00	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	28.50	5.03	1.68	0.00	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	39.64	28.10	4.52	0.50	0.75	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	35.65	15.21	5.47	0.48	0.24	0.00	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	26.54	7.19	4.42	0.00	0.00	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	50.42	32.46	4.60	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	34.71	13.04	4.00	0.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	35.26	15.08	3.67	0.82	0.61	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	43.77	31.54	6.44	0.43	0.00	0.21	0.00	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	33.79	16.23	5.33	0.22	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	46.43	33.95	4.38	0.22	0.44	0.44	0.00	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	27.38	13.69	2.03	0.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	24.85	14.91	3.31	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	45.93	33.16	5.44	0.27	1.09	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	35.58	10.88	2.94	0.59	0.88	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	23.99	22.90	5.45	0.00	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	43.73	42.29	6.73	0.00	0.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	45.63	15.61	4.80	0.00	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	30.17	15.08	0.00	0.00	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	44.55	39.05	4.51	1.00	0.50	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	18.35	10.19	0.00	0.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	56.93	35.47	7.44	0.00	0.44	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	39.73	20.97	1.10	0.00	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	39.70	12.17	2.56	0.64	1.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	66.19	45.87	5.21	0.99	0.25	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	38.27	8.35	6.96	0.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	35.36	13.26	2.21	0.00	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	61.20	31.11	6.84	1.03	1.03	0.00	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	43.76	21.44	3.50	0.00	1.75	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	31.60	18.82	3.20	0.36	2.84	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	89.22	44.89	8.42	0.00	0.28	0.28	0.28	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	51.95	18.29	5.40	0.42	1.25	0.83	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	31.47	17.48	5.83	0.00	1.17	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	67.87	27.75	9.35	0.30	0.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	60.52	25.88	3.34	1.25	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	21.66	21.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	43.41	29.55	3.69	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	54.64	27.32	7.97	1.14	0.57	0.57	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	39.24	19.21	4.84	0.28	0.69	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	65.05	28.51	5.44	0.26	1.81	0.00	0.00	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	57.91	34.75	5.58	0.43	1.72	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	33.03	14.61	4.45	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	41.90	19.48	4.54	0.27	0.00	0.27	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	92.79	59.27	9.58	2.39	1.80	0.30	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	39.97	17.94	6.92	0.57	0.14	0.28	0.14	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	61.79	31.85	7.64	0.00	0.00	0.00	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	82.04	36.71	8.85	1.11	1.55	0.66	0.00	1.33
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	34.89	18.96	5.69	0.00	0.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	58.53	33.81	6.25	0.28	0.28	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	96.60	42.03	7.13	1.47	0.49	0.00	0.00	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	29.33	27.37	5.87	0.65	0.00	1.30	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	58.51	34.11	6.17	0.29	0.59	0.00	0.29	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	94.57	51.90	12.97	2.88	0.86	0.29	0.86	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	52.34	40.39	8.24	1.65	0.82	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	50.33	31.27	7.44	0.60	1.19	0.60	0.00	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	15.07	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	16.04	1.78	5.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	22.67	11.50	2.96	0.00	0.00	0.00	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	32.61	18.94	6.31	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	20.36	18.58	5.14	0.00	0.00	0.00	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	27.94	14.90	3.73	0.93	0.93	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	22.53	20.65	6.76	0.00	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	39.69	11.72	5.06	0.00	0.00	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	31.78	25.79	6.22	0.34	0.11	0.00	0.00	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	15.47	8.84	0.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	20.15	10.26	3.30	1.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	37.33	15.56	7.78	1.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	41.15	39.55	7.48	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	7.73	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	9.09	9.09	3.03	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	36.68	21.08	5.06	0.42	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	25.88	17.71	2.72	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	18.44	17.80	3.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	12.96	22.68	0.81	1.62	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	19.64	13.59	0.00	1.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	45.68	0.00	0.00	0.00	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	48.94	26.10	6.52	3.26	0.00	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	23.76	19.01	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	25.10	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	27.58	20.47	4.09	0.00	0.22	0.22	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	20.38	14.11	4.18	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	13.35	11.35	2.67	0.00	0.00	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	12.10	16.69	2.09	0.42	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	29.66	13.31	2.47	0.19	0.95	0.38	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	19.15	31.92	7.98	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	11.56	14.96	4.76	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	49.62	67.99	9.19	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	17.16	10.46	4.19	0.00	2.09	0.00	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	19.29	15.11	1.86	0.00	0.00	0.23	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	17.56	8.11	3.78	0.27	0.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	25.44	13.03	4.41	0.21	0.00	0.00	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	178.16	167.02	11.13	0.00	0.00	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	10.42	12.41	4.47	0.50	0.00	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	13.80	9.47	2.44	0.00	0.27	0.27	0.00	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	13.60	10.65	2.04	0.00	0.68	0.23	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	18.29	11.27	6.21	0.33	0.33	0.16	0.00	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	24.60	16.04	4.56	0.36	0.00	0.00	0.00	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.85	11.67	4.24	0.00	0.00	0.00	0.00	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.80	7.20	4.20	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	20.35	11.81	2.63	0.33	0.00	0.33	0.00	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	12.85	7.64	3.09	0.16	0.16	0.16	0.00	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	28.04	21.52	6.00	0.18	0.35	0.18	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.06	10.55	5.63	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	11.03	7.36	1.84	0.46	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	21.85	10.28	1.29	0.00	0.64	0.00	0.00	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	19.66	8.62	3.10	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	73.32	48.04	12.64	0.00	0.00	2.53	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	28.74	19.16	6.02	0.22	0.89	0.22	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	15.67	9.31	2.54	0.00	0.42	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	14.95	8.07	1.42	0.24	0.95	0.00	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	22.75	6.87	4.29	0.00	1.72	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	117.36	81.25	36.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	20.33	13.66	3.33	0.33	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	27.95	9.92	3.16	0.45	0.45	0.00	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	18.25	10.71	3.97	0.00	0.40	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.93	12.07	2.79	0.00	0.00	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	19.68	10.22	1.51	0.00	0.00	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	18.90	5.54	1.30	0.00	0.98	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	16.12	6.54	1.74	0.00	0.87	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	30.76	14.02	4.07	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	16.76	13.23	0.88	0.88	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.29	12.63	3.32	0.00	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	16.87	6.94	2.98	0.00	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	13.40	2.68	0.38	0.00	0.77	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	28.13	8.47	3.02	0.91	0.00	0.00	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	28.51	14.37	2.65	0.44	0.22	0.22	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	13.55	10.16	4.07	0.00	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	102.19	56.20	10.22	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	25.61	10.36	1.83	0.00	0.00	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	14.16	4.72	0.94	0.00	0.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	28.15	9.99	1.51	0.00	0.30	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	14.24	7.12	0.79	0.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	21.54	5.67	2.27	0.00	2.27	0.00	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	75.87	40.46	10.12	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	33.42	44.47	8.07	1.12	0.50	0.25	0.25	0.50
Myoblast, donor2	11322-117D8	20.71	13.62	4.79	0.96	0.58	0.00	0.00	0.00
Myoblast, donor3	11398-118D3	45.74	36.49	10.26	0.50	0.17	0.00	0.00	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	52.97	5.69	1.31	0.29	0.00	0.00	0.00	0.15
Natural Killer Cells, donor1	11230-116C6	36.29	13.22	3.69	5.84	0.31	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	34.08	5.73	3.02	2.41	0.30	0.00	0.00	0.90
Natural Killer Cells, donor3	11387-118C1	33.13	8.65	2.39	3.50	0.37	0.00	0.55	0.74
Neural stem cells, donor1	11275-116H6	52.26	17.42	3.27	0.00	0.00	0.36	0.00	0.00
Neural stem cells, donor2	11352-117H2	75.10	34.66	7.70	0.00	0.00	0.00	0.00	1.93
Neurons, donor1	11494-119E9	67.14	18.21	3.41	0.00	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	46.45	16.95	5.50	0.22	0.00	0.00	0.00	0.66
Neurons, donor3	11655-122E8	46.86	17.27	5.76	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	8.35	3.71	1.86	0.93	0.00	0.00	0.00	0.93
Neutrophils, donor2	11314-117C9	17.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	12.83	2.44	4.28	0.61	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	27.19	8.91	3.44	0.12	0.00	0.00	0.00	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	14.98	4.23	0.65	0.00	0.00	0.00	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	23.67	11.03	3.01	0.00	0.00	0.00	0.00	0.40
Olfactory epithelial cells, donor1	11933-125I7	14.59	12.80	3.44	0.83	0.28	0.00	0.14	0.00
Olfactory epithelial cells, donor2	11934-125I8	20.26	27.79	6.80	0.58	0.29	0.00	0.00	0.43
Olfactory epithelial cells, donor3	11935-125I9	14.19	18.05	4.31	0.91	0.23	0.00	0.00	0.57
Olfactory epithelial cells, donor4	11936-126A1	21.62	20.26	5.55	0.19	0.10	0.00	0.00	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	61.39	12.04	5.42	0.00	0.00	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	16.38	9.57	3.62	0.21	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	25.15	10.29	1.14	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	18.00	13.66	3.10	0.00	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	19.54	4.89	2.15	0.20	0.20	0.00	0.00	0.39
Osteoblast, donor2	11354-117H4	39.33	19.66	2.81	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	33.59	12.62	4.09	0.36	0.00	0.00	0.00	0.71
Pancreatic stromal cells, donor1	11249-116E7	34.87	32.35	9.18	0.59	0.42	0.25	0.08	0.67
Pericytes, donor1	11491-119E6	8.23	2.45	0.33	0.00	0.11	0.00	0.00	0.11
Pericytes, donor2	11571-120E5	11.54	4.30	1.13	0.00	0.00	0.00	0.00	0.23
Pericytes, donor3	11652-122E5	19.33	11.80	4.27	1.02	0.20	0.00	0.00	0.20
Perineurial Cells, donor1	11499-119F5	40.24	9.49	4.86	0.68	0.00	0.00	0.00	0.57
Perineurial Cells, donor2	11579-120F4	24.75	13.25	3.68	0.28	0.00	0.18	0.09	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	39.52	6.69	2.87	3.51	0.32	0.00	0.00	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	26.69	8.82	2.20	4.41	0.49	0.24	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	30.54	6.34	2.59	0.78	0.00	0.00	0.00	0.39
Placental Epithelial Cells, donor1	11278-116H9	13.63	2.39	0.48	0.00	0.00	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	12.20	5.54	1.11	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	9.42	3.14	0.98	0.00	0.00	0.00	0.00	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	9.49	13.29	4.75	0.00	0.00	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	26.07	30.58	7.13	2.06	0.00	0.38	0.19	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	28.72	18.14	5.09	1.96	0.13	0.00	0.00	0.65
Preadipocyte - breast, donor2	11328-117E5	31.97	26.12	6.75	1.35	0.23	0.23	0.23	0.90
Preadipocyte - omental, donor1	11468-119C1	40.39	56.16	13.75	2.77	1.28	0.11	0.11	1.28
Preadipocyte - omental, donor2	11329-117E6	33.61	26.19	4.80	0.00	0.00	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	40.54	30.08	5.73	0.14	1.58	0.29	0.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	10.83	13.78	1.97	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	19.96	18.43	6.14	1.84	0.61	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	52.95	55.07	8.68	0.35	0.53	0.35	0.00	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	44.27	32.86	7.66	0.34	0.68	0.17	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	44.80	45.92	13.32	0.65	0.37	0.19	0.00	0.56
Preadipocyte - visceral, donor2	11357-117H7	43.72	45.10	13.35	0.92	0.92	0.00	0.00	0.92
Preadipocyte - visceral, donor3	11429-118G7	28.11	39.39	9.93	0.42	0.10	0.21	0.00	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	67.58	8.30	2.87	0.91	0.00	0.00	0.00	0.15
Prostate Epithelial Cells, donor2	11331-117E8	39.95	23.70	7.45	0.81	0.41	0.14	0.00	0.68
Prostate Epithelial Cells, donor3	11404-118D9	47.21	11.15	3.49	0.43	0.18	0.06	0.12	1.04
Prostate Stromal Cells, donor1	11254-116F3	43.85	39.52	9.00	0.68	0.23	0.11	0.11	0.68
Prostate Stromal Cells, donor2	11332-117E9	50.38	35.68	7.53	0.18	0.54	0.00	0.18	0.54
Prostate Stromal Cells, donor3	11405-118E1	24.40	24.19	5.63	0.21	0.42	0.00	0.00	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	29.20	1.82	1.46	0.36	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	62.24	9.84	4.16	0.42	0.07	0.21	0.00	0.97
Renal Epithelial Cells, donor1	11517-119H5	12.17	2.03	1.01	0.51	0.51	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	22.76	4.27	0.71	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	65.53	10.90	6.46	0.42	0.00	0.11	0.00	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	25.19	13.62	2.04	0.00	1.36	2.72	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	43.80	24.66	5.93	1.21	0.54	2.16	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	70.82	28.64	5.99	1.11	0.44	4.66	0.22	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	21.29	7.32	0.00	0.00	0.00	2.66	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	19.81	5.72	0.88	0.00	0.00	0.00	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	18.18	3.13	2.51	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	8.88	2.77	0.83	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	40.53	7.52	2.15	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	24.46	4.64	1.27	0.00	0.00	0.00	0.00	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	26.03	5.01	1.16	0.19	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	43.56	4.15	0.78	0.52	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	22.74	2.56	0.57	0.57	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	16.47	2.06	1.03	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	40.90	7.78	4.01	0.50	0.00	0.00	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	33.14	15.64	4.41	0.67	0.67	0.40	0.00	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	26.80	7.15	2.68	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	29.17	8.81	3.85	0.55	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	27.26	13.34	2.32	0.00	0.00	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	27.18	8.58	2.08	0.39	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	24.53	5.76	2.38	0.10	0.10	0.00	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	32.12	10.82	3.79	0.56	0.00	0.00	0.00	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	41.18	10.05	3.72	0.74	0.00	0.00	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	25.52	6.41	1.28	0.00	0.00	0.00	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	28.43	8.78	3.24	0.46	0.00	0.00	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	25.88	7.80	2.60	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	25.72	7.71	2.27	0.30	0.00	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	36.73	6.63	3.40	0.72	0.00	0.00	0.00	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	22.67	6.31	1.43	0.57	0.00	0.00	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	24.15	5.47	1.93	0.32	0.11	0.00	0.00	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	24.56	7.52	2.88	0.66	0.00	0.00	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	23.13	5.16	1.34	0.00	0.00	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	25.25	4.75	2.24	0.47	0.09	0.00	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	36.08	10.71	4.89	0.19	0.19	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	27.60	5.57	2.39	0.13	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	27.94	7.59	3.41	0.29	0.00	0.00	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	32.84	5.73	3.06	0.57	0.00	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	25.10	7.26	2.03	0.32	0.00	0.00	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	18.78	5.61	2.52	0.56	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	28.54	10.42	3.59	1.37	0.00	0.00	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	24.43	8.20	2.19	0.18	0.00	0.00	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	23.18	5.52	2.33	0.49	0.00	0.00	0.00	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	32.24	8.60	2.42	0.54	0.00	0.00	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	25.47	5.43	2.59	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	22.82	5.75	2.38	0.20	0.00	0.00	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	28.06	8.42	2.57	0.94	0.00	0.00	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	24.88	7.46	2.90	0.41	0.21	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	25.44	6.42	2.43	0.00	0.22	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	31.96	6.06	2.51	0.84	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	28.26	11.71	1.35	0.27	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	26.74	9.20	2.04	0.51	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	31.23	9.25	4.24	0.19	0.00	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	31.98	9.46	2.92	0.52	0.17	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	27.02	9.74	3.70	0.27	0.27	0.00	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	27.09	10.67	3.78	0.49	0.00	0.00	0.00	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	25.56	6.31	2.22	0.68	0.00	0.00	0.00	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	28.11	9.03	2.07	0.30	0.00	0.00	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	27.45	8.00	2.93	0.27	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	21.85	10.09	2.35	0.28	0.00	0.00	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	22.38	7.14	3.10	0.48	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	32.65	7.86	3.43	0.40	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	23.26	8.19	2.54	0.09	0.00	0.00	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	21.31	7.34	4.89	0.00	0.00	0.00	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	19.95	6.65	3.93	0.30	0.00	0.00	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	19.58	10.04	2.20	0.00	0.00	0.00	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	47.60	18.19	5.39	3.20	0.00	0.15	0.15	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	26.16	11.56	3.65	0.00	0.00	0.00	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	18.69	10.55	2.41	0.30	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	21.94	8.37	2.71	0.00	0.00	0.00	0.23	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	26.66	8.99	2.40	0.90	0.00	0.00	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	19.36	8.27	1.18	0.35	0.00	0.00	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	19.64	9.61	2.99	0.64	0.00	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	30.65	7.81	0.60	0.60	0.00	0.00	0.00	1.20
Schwann Cells, donor1	11498-119F4	14.29	3.39	0.75	0.19	0.00	0.00	0.00	0.38
Schwann Cells, donor2	11578-120F3	47.63	3.40	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	33.08	10.52	2.85	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor1	11220-116B5	55.32	21.91	10.96	0.55	1.10	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	28.49	14.71	3.22	0.92	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	19.17	11.34	1.86	0.82	0.21	0.00	0.21	0.00
Sertoli Cells, donor1	11255-116F4	44.73	39.76	16.57	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	22.59	25.42	5.65	0.00	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	44.43	21.38	7.39	0.70	0.35	0.00	0.00	0.62
Skeletal Muscle Cells, donor2	11358-117H8	13.73	13.73	2.17	1.45	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	25.08	5.85	1.67	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	36.45	13.67	3.77	0.79	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor5	11455-119A6	33.30	17.54	4.01	0.30	0.00	0.00	0.00	0.15
Skeletal Muscle Cells, donor6	11459-119B1	68.95	28.63	10.16	1.23	0.15	0.00	0.00	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	40.45	21.42	8.82	1.13	0.50	0.00	0.13	1.64
Skeletal Muscle Satellite Cells, donor2	11321-117D7	33.96	12.70	5.71	1.57	0.00	0.00	0.00	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	65.28	19.15	7.74	0.89	0.20	0.20	0.00	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	35.98	20.47	5.14	0.67	0.25	0.08	0.00	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	36.91	8.69	7.96	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	20.09	5.64	1.51	0.28	0.00	0.00	0.00	0.14
Skin - palm, donor1	10286-104F7	10.74	13.43	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	19.61	14.70	5.62	0.14	0.43	0.43	0.00	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	68.70	50.71	7.36	0.82	1.64	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	16.75	6.88	2.21	0.00	0.00	0.00	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	53.10	19.60	9.45	0.14	0.14	0.14	0.14	1.11
Small Airway Epithelial Cells, donor2	11334-117F2	33.48	11.25	3.94	0.42	0.28	0.14	0.00	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	51.80	17.34	5.07	8.46	0.21	0.00	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	39.57	8.92	4.80	0.30	0.30	0.07	0.00	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	45.05	66.96	13.58	0.00	0.93	0.62	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	25.57	37.35	4.67	2.00	0.22	0.67	0.44	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	31.74	21.75	10.58	1.18	0.00	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	59.45	60.11	13.92	2.21	2.21	0.88	0.22	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	43.32	84.66	10.63	2.76	1.97	0.39	1.18	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	33.22	30.90	8.50	1.55	0.00	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	12.01	5.00	4.00	1.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	31.54	31.27	8.78	1.06	0.40	0.27	0.40	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	23.27	19.95	4.88	1.33	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	69.52	75.79	12.80	2.18	1.28	0.51	0.51	1.15
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	29.63	12.37	5.54	0.65	0.00	0.33	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	27.17	17.13	4.43	0.00	0.30	0.00	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	30.47	23.77	5.69	0.85	0.57	0.28	0.00	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	19.85	5.37	2.11	0.65	0.16	0.00	0.00	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	35.62	28.62	7.31	1.22	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	22.48	11.62	2.78	0.76	0.25	0.00	0.00	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	6.12	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	26.23	28.61	7.15	0.48	1.91	0.00	0.00	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	28.90	13.72	4.13	1.77	0.15	0.15	0.00	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	22.60	16.36	4.30	0.86	0.00	0.00	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	34.74	16.58	4.62	0.42	0.10	0.00	0.00	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	54.14	74.40	11.45	2.32	2.01	0.62	1.08	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	28.02	38.80	9.70	2.16	1.08	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	46.32	62.46	13.45	1.20	1.20	0.00	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	14.00	2.39	0.34	0.34	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	32.59	8.72	4.16	0.31	0.00	0.00	0.00	1.18
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	34.42	38.65	7.85	0.60	0.81	0.00	0.70	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	48.92	48.47	12.29	1.37	0.91	0.23	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	27.78	44.08	9.06	0.60	1.81	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	57.75	14.84	6.36	0.26	0.00	0.00	0.00	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	29.96	24.63	5.99	0.40	0.00	0.00	0.00	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	28.55	26.05	5.38	0.25	0.63	0.00	0.13	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	12.94	39.06	7.86	0.51	0.25	0.00	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	49.60	76.59	16.28	1.51	0.90	0.45	0.45	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.00	13.50	6.00	0.00	0.00	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	71.07	65.90	16.80	2.58	0.00	6.46	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	17.67	4.65	2.33	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	31.81	46.45	7.57	1.01	0.50	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	36.04	38.86	8.78	1.57	0.94	0.00	0.94	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6.78	2.65	1.77	0.29	0.00	0.00	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	41.65	14.33	5.91	0.08	0.00	0.00	0.00	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	23.36	9.34	1.87	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	50.95	46.20	9.79	1.58	1.44	0.29	0.43	1.44
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	37.73	25.75	8.41	0.00	0.25	0.25	0.00	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	29.52	34.97	4.89	0.56	0.56	0.19	0.00	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	42.90	9.22	3.91	0.28	0.00	0.14	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	34.19	10.22	4.11	0.08	0.00	0.00	0.00	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	14.76	0.95	2.38	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	49.18	42.08	6.61	1.71	0.73	0.24	0.00	1.47
Smooth Muscle Cells - Uterine, donor1	11258-116F7	44.63	51.92	8.84	1.10	1.33	0.22	0.00	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	62.03	41.25	9.66	0.88	0.29	0.00	0.29	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	15.55	20.21	3.89	0.19	0.58	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	15.07	28.30	5.02	0.26	1.32	0.26	0.53	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	10.79	23.43	2.23	0.37	0.00	0.00	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	15.81	29.47	5.75	0.72	1.80	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	23.28	31.23	4.54	0.28	0.57	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	27.57	16.94	3.54	0.00	0.39	0.00	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	13.46	22.86	3.81	0.51	0.25	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	15.57	15.97	4.39	0.40	0.40	0.00	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	16.30	24.24	3.34	0.00	0.00	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	19.71	15.13	1.83	0.00	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	24.91	11.45	3.53	0.50	0.00	0.00	0.00	0.34
Synoviocyte, donor2	11368-117I9	13.91	9.39	2.18	0.00	0.17	0.00	0.00	0.34
Synoviocyte, donor3	11440-118H9	13.40	11.62	3.35	0.22	0.22	0.00	0.00	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	39.31	13.22	2.50	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	11.89	5.95	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	22.46	9.72	3.01	0.46	0.00	0.23	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	33.84	6.59	3.58	0.36	0.14	0.14	0.00	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	17.01	7.73	3.09	0.00	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	14.89	12.60	0.57	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	33.95	14.39	4.55	0.62	0.25	0.62	0.12	0.25
Urethra, donor2	10319-105A4	12.59	21.58	1.80	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	20.99	4.52	3.72	0.53	0.53	0.27	0.00	0.27
Urothelial Cells, donor2	11600-120H7	16.02	5.21	1.20	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	9.17	2.52	1.38	0.46	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	67.54	26.30	10.25	1.56	0.22	0.45	0.00	1.78
Whole blood (ribopure), donor090309, donation1	12179-129A1	32.03	10.68	0.89	1.78	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	48.61	8.58	7.15	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	26.01	4.11	1.37	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	33.75	3.79	2.07	1.38	0.00	0.00	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	26.15	4.07	1.74	1.16	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	28.11	1.04	3.12	1.04	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	34.88	4.59	1.84	0.00	0.00	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	28.30	1.83	1.83	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	51.94	12.21	5.18	0.25	0.12	0.12	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	27.28	6.16	4.40	0.00	0.00	0.00	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	33.52	1.40	3.35	0.56	0.00	0.00	0.00	0.28
achilles tendon, donor2	10292-104G4	45.46	39.26	8.27	8.27	0.00	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	103.77	5.10	3.31	0.25	0.00	0.00	0.00	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	52.94	6.04	2.79	0.23	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	61.61	22.67	11.63	0.47	0.00	0.00	0.00	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	48.98	10.07	2.45	0.00	0.00	0.00	0.00	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	58.75	4.50	3.09	0.56	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	81.21	15.86	6.56	0.85	0.00	0.00	0.00	1.27
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	19.60	1.63	1.91	0.54	0.00	0.54	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	41.86	4.41	3.97	0.44	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	47.37	4.90	0.82	0.41	0.00	0.41	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	39.22	4.66	1.16	0.39	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	53.54	1.66	0.74	0.18	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	46.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	62.28	12.55	4.88	0.93	0.23	0.23	0.00	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	47.64	3.11	2.07	0.00	0.00	0.00	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	42.08	3.80	2.34	0.58	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	31.60	1.86	2.32	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	70.32	2.47	2.88	0.00	0.00	0.00	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	18.42	0.31	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	26.88	0.43	0.43	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	30.03	1.21	0.61	0.00	0.00	0.00	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	33.22	1.20	0.72	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	43.88	8.69	3.34	0.45	0.00	0.00	0.00	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	45.03	12.01	4.00	0.00	0.00	0.00	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	20.44	3.72	1.86	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	13.18	1.13	0.38	0.75	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	42.74	3.93	2.62	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	3.75	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	56.28	11.54	8.71	0.00	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	27.30	11.32	3.88	0.16	0.16	0.00	0.00	0.47
adipose, donor1	10184-103D4	43.39	15.25	7.04	0.59	0.00	0.00	0.00	0.00
adipose, donor2	10185-103D5	26.36	8.52	4.46	0.00	0.00	0.00	0.00	0.00
adipose, donor3	10186-103D6	36.76	5.72	4.90	0.00	0.00	0.00	0.00	0.00
adipose, donor4	10187-103D7	80.61	6.93	2.60	0.00	0.00	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	55.87	0.95	1.10	0.00	0.00	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	7.28	3.64	7.28	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	39.49	7.47	3.60	0.13	0.00	0.00	0.00	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	15.72	21.08	6.07	0.36	0.00	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	30.84	23.18	5.10	0.70	0.23	0.46	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	27.72	21.98	4.73	0.34	0.00	0.00	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	21.51	18.85	5.89	0.29	0.00	0.29	0.00	0.00
amygdala - adult, donor10196	10167-103B5	40.32	8.30	0.00	0.00	0.00	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	52.11	13.38	4.26	1.62	0.00	0.61	0.00	0.41
amygdala, newborn, donor10223	10360-105E9	30.34	13.88	2.26	1.29	0.00	0.00	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	28.39	9.68	2.93	0.89	0.13	0.13	0.00	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	33.09	13.90	3.53	0.22	0.00	0.00	0.00	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	38.75	2.00	0.00	0.33	0.33	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	12.55	4.90	1.18	0.00	0.20	0.00	0.00	0.00
appendix, adult	10189-103D9	32.21	10.87	2.72	0.78	0.00	0.00	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	124.85	2.41	2.41	1.03	0.00	0.00	0.00	0.69
artery, adult	10190-103E1	17.66	9.51	2.72	0.00	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	101.84	15.36	5.50	0.29	0.14	0.14	0.00	0.43
b cell line:RPMI1788	10427-106D4	81.64	8.33	6.25	1.34	0.00	0.00	0.00	2.08
basal cell carcinoma cell line:TE 354.T	10702-109G9	29.96	19.42	5.83	0.55	0.00	0.00	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	86.63	36.91	10.42	0.60	0.30	0.00	0.30	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	24.10	4.85	2.34	0.33	0.00	0.00	0.00	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	21.81	3.36	1.12	0.00	0.00	0.00	0.00	0.56
bladder, adult, pool1	10011-101C2	18.79	6.84	3.48	0.22	0.00	0.33	0.00	0.00
blood, adult, pool1	10053-101G8	11.07	4.43	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	17.98	11.99	2.57	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	33.07	20.92	4.05	0.67	0.00	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	27.68	5.13	2.05	0.00	0.00	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	37.53	6.68	1.67	0.45	0.00	0.00	0.00	0.00
brain, fetal, pool1	10085-102B4	18.70	13.36	8.01	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	22.80	8.26	2.64	0.00	0.00	0.00	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	41.57	10.24	4.87	0.62	0.00	0.00	0.00	0.62
breast, adult, donor1	10080-102A8	25.25	17.05	4.42	0.00	0.00	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	60.98	5.97	5.97	0.00	0.00	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	36.49	6.18	2.16	1.55	0.00	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	34.99	14.27	8.06	0.69	0.00	0.00	0.00	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	31.23	11.14	6.78	0.48	0.00	0.00	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	82.28	2.35	1.41	1.41	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	78.86	11.05	4.16	0.22	0.00	0.11	0.00	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	32.64	7.29	2.22	0.00	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	61.49	25.55	7.99	0.53	0.00	0.00	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	34.54	5.76	4.61	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	55.55	12.88	3.51	1.67	0.17	0.00	0.00	0.17
caudate nucleus, adult, donor10258	10379-105H1	29.80	5.35	2.29	0.00	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	32.23	10.99	3.66	1.10	1.46	0.00	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	58.27	5.83	0.00	2.91	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	56.15	11.10	4.70	2.56	0.00	0.00	0.00	0.00
cerebellum, adult, pool1	10083-102B2	21.04	7.24	3.10	1.38	0.00	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	46.50	12.45	5.81	1.66	0.00	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	32.78	10.59	2.52	0.00	0.00	0.00	0.00	0.25
cerebrospinal fluid, donor2	10294-104G6	21.93	6.58	4.39	0.00	0.00	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	48.31	8.05	5.75	0.72	0.14	0.00	0.00	0.86
cervical cancer cell line:ME-180	10553-107I4	46.40	6.79	2.49	0.50	0.17	0.17	0.00	0.83
cervix, adult, pool1	10013-101C4	27.61	17.74	4.09	0.31	0.10	0.10	0.00	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	35.67	11.57	2.37	1.11	0.00	0.00	0.00	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	20.90	19.59	0.00	0.00	2.61	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	55.18	6.21	4.47	0.37	0.00	0.00	0.00	1.24
choriocarcinoma cell line:SCH	10785-110H2	70.11	1.97	0.99	0.37	0.00	0.00	0.00	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	63.33	3.56	3.32	0.24	0.00	0.00	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	26.50	10.26	3.99	0.00	0.00	0.00	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	43.05	25.85	5.47	0.60	0.10	0.10	0.10	0.50
chorionic membrane cells, donor3	12240-129G8	40.11	10.44	5.49	0.00	0.00	0.55	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	27.26	11.11	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	22.86	6.53	1.73	0.19	0.00	0.00	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	31.04	1.48	1.06	0.00	0.00	0.00	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	49.31	6.68	3.08	0.26	0.00	0.00	0.00	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	48.62	4.60	2.90	0.00	0.00	0.00	0.00	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	44.39	8.35	2.65	0.61	0.00	0.00	0.20	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	29.15	2.65	0.88	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	40.40	2.87	1.04	0.26	0.00	0.00	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	43.89	11.43	5.71	0.00	0.00	0.00	0.00	1.14
clear cell carcinoma cell line:TEN	10636-108I6	41.12	4.86	3.82	0.35	0.00	0.00	0.00	0.69
colon carcinoma cell line:CACO-2	10513-107D9	56.38	9.15	4.39	0.37	0.00	0.18	0.00	0.55
colon carcinoma cell line:COLO-320	10420-106C6	49.41	1.14	1.90	1.90	0.00	0.00	0.00	0.38
colon, adult, donor1	10082-102B1	32.13	15.47	2.38	0.00	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	37.48	10.93	4.94	0.24	0.00	0.00	0.00	0.24
colon, fetal, donor1	10070-101I7	28.43	9.27	4.94	0.00	1.24	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	87.09	4.58	9.17	0.00	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	58.64	4.67	1.70	0.85	0.00	0.00	0.00	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	54.18	2.26	1.36	0.15	0.00	0.15	0.00	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	62.75	2.82	1.41	0.56	0.00	0.00	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	44.89	11.50	4.53	1.33	0.00	0.00	0.00	0.22
cruciate ligament, donor2	10295-104G7	30.80	14.59	4.05	0.00	0.81	0.00	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	17.66	13.64	4.82	0.00	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	36.96	7.68	2.16	0.00	0.00	0.00	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	52.12	1.61	0.92	0.46	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	84.63	10.00	5.90	0.00	0.00	0.00	0.00	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	38.76	13.48	4.33	0.48	0.24	0.00	0.00	0.48
ductus deferens, adult	10196-103E7	9.47	9.97	2.99	1.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	43.21	15.84	7.20	0.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	44.14	11.03	5.15	2.21	0.00	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	22.05	6.69	1.98	1.24	0.00	0.08	0.00	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	42.42	12.21	2.66	0.67	0.67	0.00	0.00	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	45.57	13.61	4.30	0.29	0.14	0.00	0.00	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	22.81	1.23	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	26.94	1.51	0.30	0.00	0.30	0.00	0.00	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	26.24	2.78	0.62	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	14.45	2.63	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	47.60	7.04	3.35	0.67	0.00	0.00	0.00	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	36.97	8.52	4.71	0.00	0.00	0.00	0.00	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	36.83	4.82	3.22	0.00	0.16	0.00	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	59.25	9.78	4.89	0.44	0.11	0.00	0.00	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	71.38	10.45	4.84	0.33	0.11	0.33	0.00	0.99
epididymis, adult	10197-103E8	20.72	8.16	1.67	0.42	0.00	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	12.95	18.27	5.32	0.35	0.00	0.00	0.00	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	18.09	9.44	4.33	0.00	0.00	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	55.04	3.93	2.49	0.52	0.00	0.13	0.00	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	53.54	6.20	2.36	0.30	0.20	0.00	0.00	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	54.67	5.60	2.58	0.67	0.22	0.00	0.00	0.00
esophagus, adult, pool1	10015-101C6	38.01	29.52	7.96	0.64	0.74	0.32	0.00	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	43.08	22.67	7.39	1.75	0.38	0.13	0.25	1.13
eye - muscle inferior rectus, donor1	10272-104E2	16.90	12.07	4.83	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	27.35	27.35	2.10	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	22.32	16.37	1.49	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	26.37	13.76	2.29	1.15	0.00	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	14.57	13.12	4.37	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	30.00	11.69	2.54	0.00	0.25	0.00	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	44.75	8.72	3.08	0.13	0.00	0.13	0.00	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	65.77	12.11	4.99	0.24	0.47	0.00	0.00	0.95
frontal lobe, adult, pool1	10040-101F4	46.07	9.95	2.44	1.22	0.00	0.09	0.00	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	71.16	2.70	0.90	0.00	0.00	0.00	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	36.12	11.34	6.03	0.18	0.00	0.00	0.00	1.01
gall bladder, adult	10198-103E9	23.90	12.80	5.31	0.24	0.24	0.00	0.00	0.97
gamma delta positive T cells, donor1	11937-126A2	27.92	2.15	1.61	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	29.51	4.48	2.61	1.49	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	40.98	13.94	2.32	0.00	0.00	0.00	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	73.88	11.60	4.06	0.97	0.19	0.00	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	47.06	10.33	3.93	0.66	0.00	0.00	0.00	0.82
gastric cancer cell line:GSS	10560-108A2	52.17	1.83	0.92	0.92	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	73.56	2.51	0.69	0.23	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	161.10	37.98	14.57	1.61	1.26	0.46	0.23	3.10
giant cell carcinoma cell line:Lu99B	10433-106E1	48.43	20.99	7.28	0.42	0.00	0.00	0.00	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	36.17	8.23	2.24	0.00	0.25	0.00	0.00	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	22.06	28.29	8.66	0.53	0.11	0.00	0.00	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	25.98	28.23	7.02	0.42	0.00	0.00	0.00	0.14
glioblastoma cell line:T98G	10485-107A8	33.55	34.55	6.84	0.66	0.11	0.00	0.00	0.33
glioma cell line:GI-1	10413-106B8	30.75	1.76	1.46	0.00	0.29	0.00	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	36.45	11.66	0.73	0.00	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	61.51	16.11	4.15	0.98	0.00	0.24	0.00	0.24
globus pallidus, adult, donor10258	10367-105F7	28.75	6.85	4.11	1.37	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	29.31	10.66	5.86	0.53	0.53	0.53	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	127.25	29.37	2.45	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	10.45	0.00	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	37.44	13.12	7.36	0.64	0.00	0.00	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	67.95	3.21	1.38	0.92	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	69.50	7.32	1.83	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	61.83	5.15	1.93	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	64.68	5.75	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	88.48	4.12	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	51.86	8.83	0.00	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	52.01	3.16	1.44	0.29	0.29	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	26.91	6.58	0.60	0.30	0.00	1.20	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	21.44	10.46	4.45	1.57	0.00	0.00	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	29.14	2.50	2.50	0.00	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	19.79	6.53	2.24	0.00	0.00	0.00	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	11.07	4.26	0.43	0.00	0.00	0.43	0.00	0.00
heart, adult, pool1	10016-101C7	28.52	3.91	2.30	0.00	0.00	0.00	0.00	0.23
heart, fetal, pool1	10046-101G1	52.26	7.39	3.49	1.13	0.10	0.51	0.00	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	38.26	30.54	9.56	0.00	1.23	0.00	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	40.43	5.95	2.38	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	61.21	6.96	2.32	0.44	0.00	0.00	0.00	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	60.08	6.19	1.94	0.24	0.12	0.12	0.00	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	62.15	4.75	2.73	0.30	0.00	0.00	0.00	0.20
hepatoma cell line:Li-7	10484-107A7	43.93	13.79	4.89	1.00	0.11	0.00	0.11	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	51.15	4.52	2.81	0.00	0.00	0.00	0.00	0.30
hippocampus - adult, donor10196	10169-103B7	31.23	11.36	4.73	0.00	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	44.29	18.57	4.49	0.61	0.00	0.00	0.00	0.20
hippocampus, adult, donor10258	10374-105G5	31.87	5.98	2.49	0.00	0.50	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	35.60	8.11	3.52	1.06	0.00	0.00	0.35	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	87.89	9.16	6.10	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	71.08	5.50	2.95	0.59	0.00	0.00	0.00	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	71.09	5.33	2.54	0.00	0.00	0.00	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	54.13	8.46	3.95	1.13	0.56	0.00	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	50.87	5.94	3.87	0.77	0.26	0.00	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	52.77	10.63	4.56	0.00	1.14	0.00	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	37.08	11.68	3.50	0.58	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	40.07	11.20	5.39	0.65	0.22	0.00	0.00	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	27.53	10.84	4.17	0.00	0.00	0.00	0.42	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	43.33	13.97	5.21	1.18	0.00	0.00	0.00	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	33.27	10.13	3.70	0.32	0.00	0.00	0.00	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	32.99	10.77	5.39	0.67	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	63.69	3.76	1.88	0.78	0.00	0.00	0.00	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	61.90	4.42	1.47	0.49	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	63.71	6.11	2.62	0.87	0.00	0.00	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	49.83	10.12	2.86	0.19	0.19	0.00	0.00	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	42.74	9.59	3.49	0.00	0.44	0.00	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	29.99	9.00	3.50	0.00	0.00	0.00	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	28.45	5.46	2.64	0.75	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	37.74	7.28	4.09	0.91	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	35.08	7.52	2.19	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	24.99	10.29	4.25	0.00	0.00	0.00	0.00	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	29.32	9.00	3.77	1.16	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	23.32	7.17	5.08	0.30	0.00	0.00	0.00	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	75.38	6.47	3.88	0.18	0.00	0.00	0.00	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	70.47	6.85	1.43	0.57	0.00	0.29	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	74.31	6.53	4.08	0.00	0.00	0.00	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	48.94	8.80	3.52	0.00	0.00	0.35	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	44.66	3.80	1.58	0.63	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	43.88	7.87	3.93	0.30	0.00	0.00	0.00	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	28.96	5.69	2.59	1.03	0.00	0.00	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	31.22	9.96	2.66	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	20.52	12.06	4.36	0.26	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	28.38	8.95	3.07	0.51	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	27.26	10.60	5.30	2.27	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	30.92	8.40	4.37	0.34	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	78.97	6.76	2.42	0.72	0.24	0.00	0.00	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	61.06	6.24	3.12	0.89	0.00	0.45	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	70.73	2.44	2.44	0.00	0.00	0.00	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	51.96	10.70	1.22	0.31	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	139.89	61.81	13.01	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	44.02	13.57	3.31	0.33	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	35.57	8.21	4.93	0.55	0.00	0.00	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	29.31	11.22	3.26	0.00	0.36	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	34.16	10.68	2.49	0.71	0.00	0.00	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	21.48	9.55	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	48.48	14.63	4.06	0.14	0.14	0.00	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	27.75	8.35	1.89	0.27	0.00	0.00	0.00	0.27
immature langerhans cells, donor1	11904-125F5	272.66	303.17	54.48	8.96	2.18	0.73	0.97	5.09
immature langerhans cells, donor2	11905-125F6	119.61	84.76	29.31	18.22	1.58	0.79	1.58	2.38
insula, adult, pool1	10039-101F3	42.77	7.57	3.31	1.23	0.00	0.00	0.00	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	22.11	3.58	2.28	0.33	0.33	0.00	0.00	0.65
kidney, adult, pool1	10017-101C8	26.13	11.61	3.60	0.20	0.10	0.10	0.00	0.20
kidney, fetal, pool1	10045-101F9	26.46	10.54	3.11	0.35	0.14	0.28	0.00	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	48.29	7.10	1.70	0.14	0.00	0.00	0.00	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	20.18	3.32	2.21	0.41	0.00	0.00	0.00	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	53.21	4.95	2.75	0.37	0.18	0.00	0.00	0.37
left atrium, adult, donor1	10079-102A7	17.98	7.08	0.00	0.00	0.54	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	21.24	10.11	2.53	0.00	0.00	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	25.45	8.48	3.01	0.27	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	14.37	25.87	6.11	1.44	0.72	0.36	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	17.39	25.54	9.24	1.09	0.54	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	20.15	33.27	9.96	0.00	0.00	0.00	0.00	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	19.05	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	35.55	20.91	6.27	0.00	3.14	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	52.30	5.08	2.24	0.35	0.12	0.12	0.00	0.24
liposarcoma cell line:KMLS-1	10782-110G8	24.52	27.02	5.78	1.09	0.16	0.00	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	53.37	11.70	5.12	0.12	0.24	0.00	0.00	0.12
liver, adult, pool1	10018-101C9	24.96	3.24	1.78	0.00	0.00	0.32	0.00	0.00
liver, fetal, pool1	10086-102B5	17.87	0.94	0.00	0.00	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	37.62	12.25	5.10	0.15	0.00	0.15	0.00	0.29
locus coeruleus, adult, donor10252	10165-103B3	49.46	11.81	2.40	0.37	0.00	0.00	0.00	0.00
locus coeruleus, adult, donor10258	10375-105G6	26.80	7.90	3.67	0.28	0.00	0.00	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	23.98	12.20	1.68	0.42	0.00	0.42	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	21.17	12.32	3.74	0.14	0.14	0.00	0.00	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	22.75	3.45	4.83	0.00	0.00	0.00	0.00	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	21.35	10.81	2.90	0.26	0.13	0.00	0.00	0.00
lung, adult, pool1	10019-101D1	42.76	16.54	4.73	0.59	0.00	1.54	0.00	0.95
lung, fetal, donor1	10068-101I5	56.23	46.81	7.71	1.43	0.29	3.71	0.00	0.86
lung, right lower lobe, adult, donor1	10075-102A3	40.78	34.37	6.42	1.37	1.83	1.83	0.00	0.00
lymph node, adult, donor1	10077-102A5	23.19	3.31	3.79	0.00	0.00	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	51.51	4.16	1.32	0.44	0.00	0.00	0.00	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	48.15	1.21	0.75	0.30	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	67.96	4.25	3.40	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	29.30	27.97	14.21	0.00	0.89	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	27.60	23.87	6.43	0.21	0.42	1.45	0.00	0.62
mature adipocyte, donor3	12233-129G1	28.21	48.60	12.09	0.24	0.24	0.24	0.00	1.19
mature adipocyte, donor4	12234-129G2	24.22	42.38	14.21	1.32	0.00	0.26	0.00	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	71.48	2.38	0.95	0.24	0.00	0.00	0.00	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	36.10	12.41	0.00	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	51.68	11.59	1.66	1.66	0.18	0.00	0.00	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	30.18	6.04	1.59	0.32	0.00	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	45.63	25.16	5.97	0.85	0.00	0.00	0.85	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	41.01	6.41	2.53	0.51	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	53.69	10.61	4.46	1.49	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	30.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	28.71	0.00	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	45.58	16.15	3.59	0.00	0.36	0.00	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	31.15	9.09	5.19	0.00	0.00	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	49.23	13.93	4.64	1.08	0.00	0.15	0.00	0.00
medulla oblongata, adult, pool1	10038-101F2	37.63	12.16	4.49	0.73	0.00	0.08	0.00	0.08
medulla oblongata, newborn, donor10223	10361-105F1	33.33	11.80	2.78	0.00	0.00	0.00	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	36.53	4.65	2.44	0.22	0.22	0.00	0.00	0.44
medulloblastoma cell line:ONS-76	10759-110E3	39.37	6.24	2.08	0.00	0.00	0.00	0.00	0.37
melanoma cell line:COLO 679	10514-107E1	46.00	15.96	4.02	1.44	0.29	0.00	0.00	0.57
melanoma cell line:G-361	10465-106H6	49.68	17.65	8.14	1.09	1.36	0.00	0.00	0.54
meningioma cell line:HKBMM	10691-109F7	34.37	14.65	5.97	0.72	0.36	0.00	0.00	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	48.46	6.17	5.29	1.76	0.00	0.00	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	59.10	5.18	1.30	0.52	0.00	0.00	0.00	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	42.65	68.12	16.57	1.84	0.61	0.15	0.00	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	47.99	84.35	14.18	3.27	0.55	0.18	0.00	2.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	34.78	59.22	9.94	3.31	0.00	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	38.07	18.82	7.30	0.28	0.42	0.00	0.00	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	28.89	17.14	4.04	0.19	0.39	0.00	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	18.74	27.07	4.16	1.39	1.39	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	83.41	141.94	23.00	4.98	3.60	0.69	0.51	2.06
mesenchymal precursor cell - cardiac, donor2	11753-123G7	43.25	47.04	10.12	1.50	0.46	0.23	0.00	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	55.18	49.47	10.48	1.06	0.27	0.53	0.00	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	114.51	167.04	28.76	3.92	0.81	0.68	0.27	2.30
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	163.03	234.73	36.85	4.27	2.99	0.85	2.99	3.27
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	62.25	84.31	17.79	3.29	2.63	0.66	0.33	1.65
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	100.04	111.25	17.99	4.29	1.11	0.00	0.69	2.35
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	37.00	49.92	12.92	1.75	1.75	0.35	0.00	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	108.82	148.02	19.80	6.53	2.04	0.61	0.82	2.65
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	67.22	59.31	10.06	2.52	1.80	0.36	0.72	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	33.83	26.69	7.14	1.14	0.10	0.10	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	33.06	53.35	10.49	1.37	1.82	0.68	0.68	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	154.40	234.95	35.24	6.29	1.68	0.00	2.52	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	87.27	81.89	15.99	1.79	1.05	0.60	0.30	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	103.46	156.94	28.97	4.99	1.58	0.44	1.05	2.28
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	121.49	80.26	15.83	3.68	4.05	1.10	0.00	2.21
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	67.25	73.54	12.59	4.01	2.86	0.57	1.14	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	48.42	17.68	7.58	0.00	0.42	0.42	0.00	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	21.01	28.77	4.57	0.00	0.00	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	24.56	32.48	9.46	0.77	1.02	0.00	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	28.53	30.63	7.33	0.26	0.52	0.00	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	26.19	28.34	8.01	0.62	0.00	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	19.53	33.19	6.59	0.71	0.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	21.32	35.54	7.45	0.34	0.00	0.00	0.00	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	27.90	29.87	8.25	0.39	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	20.39	24.56	7.41	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	30.28	36.34	9.52	0.29	0.00	0.00	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	32.57	37.03	7.59	0.45	0.45	0.22	0.00	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	26.20	34.13	9.13	0.48	0.24	0.24	0.00	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	20.53	33.00	7.33	0.73	0.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	24.50	34.24	10.74	0.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	26.61	29.88	7.78	0.00	0.00	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	27.49	38.23	11.17	0.43	0.00	0.00	0.00	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	19.14	19.14	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	25.82	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	27.28	33.13	6.82	0.00	0.65	0.00	0.00	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	17.46	30.55	8.73	1.45	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	25.05	26.65	12.26	1.07	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	18.81	28.62	12.27	0.00	0.00	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	22.55	28.38	7.77	0.78	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	29.38	2.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	15.90	25.83	7.95	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	38.14	9.53	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	23.72	30.24	9.49	0.00	0.59	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	24.37	15.84	4.87	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	27.87	20.90	8.23	0.00	0.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	15.52	14.49	6.55	0.34	0.69	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	10.75	0.00	2.15	0.00	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	11.98	3.99	0.00	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	6.89	6.89	0.00	0.00	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	14.26	13.45	4.07	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	9.53	16.68	3.97	0.00	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.61	15.92	2.36	0.00	0.00	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	8.42	13.40	3.43	0.31	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	6.68	17.38	2.67	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	11.83	21.29	7.10	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	10.27	12.84	2.57	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	19.96	31.67	2.75	2.07	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	19.79	17.32	5.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	14.58	12.34	6.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	10.81	17.17	3.82	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	18.54	6.85	3.63	0.00	0.00	0.00	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	13.08	2.18	0.00	0.00	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	8.87	7.60	1.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	34.59	51.59	7.89	1.82	1.21	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	40.67	63.27	18.08	9.04	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	42.83	44.48	11.53	1.65	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	19.05	24.80	5.16	0.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	14.60	22.07	3.57	0.97	0.32	0.32	0.00	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	22.41	22.41	5.09	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	16.25	6.19	3.09	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	59.53	21.26	11.34	0.47	0.24	0.00	0.24	1.42
mesothelioma cell line:ACC-MESO-4	10494-107B8	21.78	6.49	2.78	0.00	0.46	0.00	0.00	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	12.82	8.55	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	17.26	10.99	3.08	0.00	0.00	0.00	0.00	0.62
mesothelioma cell line:Mero-25	10850-111F4	25.42	6.35	2.95	0.00	0.00	0.00	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	36.92	14.67	4.40	1.47	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	26.79	9.74	4.43	0.22	0.22	0.00	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	45.99	16.82	4.47	0.26	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	26.72	5.45	3.23	0.68	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	16.94	4.55	2.27	0.25	0.00	0.00	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	32.71	8.70	4.35	0.21	0.00	0.00	0.00	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	22.69	11.26	2.98	0.17	0.00	0.33	0.00	0.17
mesothelioma cell line:NCI-H226	10846-111E9	24.61	19.73	7.78	0.54	0.00	0.00	0.00	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	20.16	10.08	4.10	0.17	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	18.83	12.72	3.82	0.51	0.00	0.00	0.00	0.76
mesothelioma cell line:No36	10857-111G2	36.53	7.50	1.96	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	40.91	22.76	9.48	0.27	0.27	0.00	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	135.50	146.24	40.50	0.96	0.58	0.00	0.19	2.88
migratory langerhans cells, donor2	11902-125F3	116.25	106.97	25.77	3.66	0.24	0.24	0.00	1.22
migratory langerhans cells, donor3	11903-125F4	111.10	61.20	15.61	1.62	0.18	0.00	0.00	1.97
mixed mullerian tumor cell line:HTMMT	10689-109F5	70.19	8.81	4.57	0.00	0.00	0.00	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	41.12	3.18	1.70	0.21	0.21	0.00	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	40.08	18.66	9.21	0.00	0.23	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	46.24	3.43	2.47	0.38	0.00	0.00	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	40.84	5.54	1.66	0.37	0.00	0.00	0.00	0.55
myeloma cell line:PCM6	10474-106I6	29.65	7.91	3.76	0.40	0.00	0.00	0.00	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	10.15	8.62	4.06	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	39.23	18.24	6.67	1.18	0.00	0.00	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	61.73	11.25	4.23	0.78	0.11	0.11	0.00	0.78
nasal epithelial cells, donor1, tech_rep2	12226-129F3	57.21	10.08	5.22	0.22	0.15	0.15	0.00	0.29
nasal epithelial cells, donor2	12227-129F4	60.17	14.90	3.86	0.00	0.00	0.00	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	52.22	12.42	3.22	0.46	0.00	0.00	0.00	0.69
neuroblastoma cell line:NB-1	10539-107G8	77.64	7.67	3.37	0.75	0.00	0.00	0.00	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	62.42	4.64	1.90	0.21	0.00	0.00	0.00	0.21
neuroblastoma cell line:NH-12	10555-107I6	72.68	2.05	0.00	1.12	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	32.03	2.14	1.19	0.24	0.00	0.00	0.00	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	30.88	6.97	1.74	0.00	0.00	0.00	0.00	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	39.65	8.05	2.62	0.20	0.00	0.00	0.00	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	32.42	13.99	8.26	0.64	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	24.49	27.95	10.38	0.00	0.53	0.00	0.00	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	107.05	3.55	2.20	1.86	0.17	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	93.66	16.81	4.00	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	23.40	12.50	4.49	1.28	0.00	0.00	0.32	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	20.50	21.28	3.42	0.53	0.00	0.00	1.05	0.53
nucleus accumbens, adult, pool1	10037-101F1	45.28	9.47	2.91	1.12	0.00	0.09	0.00	0.09
occipital cortex - adult, donor10196	10172-103C1	55.63	10.30	2.06	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	53.94	12.34	1.88	1.07	0.00	0.00	0.00	0.54
occipital cortex, newborn, donor10223	10355-105E4	45.86	22.56	3.28	0.73	0.00	0.36	0.73	0.73
occipital lobe, adult, donor1	10076-102A4	38.84	10.76	6.30	0.79	0.00	0.26	0.00	0.26
occipital lobe, fetal, donor1	10073-102A1	84.53	52.78	26.60	0.43	0.00	0.00	0.00	0.43
occipital pole, adult, pool1	10036-101E9	20.50	3.31	0.95	0.79	0.00	0.00	0.00	0.00
olfactory region, adult	10195-103E6	40.50	7.26	1.91	0.57	0.00	0.00	0.00	0.38
optic nerve, donor1	10277-104E7	66.03	8.00	4.00	2.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	56.16	6.38	2.62	0.57	0.00	0.00	0.00	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	65.81	6.18	3.57	0.00	0.00	0.00	0.00	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	29.80	5.76	2.20	0.00	0.00	0.00	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	55.10	5.78	2.08	0.46	0.12	0.12	0.00	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	29.69	21.46	5.59	0.29	0.88	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	62.60	19.62	14.02	0.93	1.87	0.93	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	24.81	7.42	2.12	0.42	0.00	0.00	0.00	0.21
ovary, adult, pool1	10020-101D2	24.46	7.77	3.23	0.17	0.00	0.00	0.00	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	68.38	21.27	7.33	0.18	0.37	0.18	0.00	0.37
pancreas, adult, donor1	10049-101G4	21.63	2.82	0.00	0.94	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	48.92	5.31	3.35	0.00	0.28	0.00	0.00	1.68
papillary adenocarcinoma cell line:8505C	10437-106E5	31.86	6.47	3.92	0.17	0.00	0.00	0.00	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	37.59	10.10	4.80	0.83	0.33	0.00	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	43.38	7.50	2.47	0.92	0.00	0.00	0.00	0.09
parietal cortex, adult, donor10258	10373-105G4	33.76	6.61	0.73	0.73	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	33.86	3.76	0.94	0.00	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	42.47	7.41	3.14	0.57	0.00	0.00	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	37.01	6.61	2.47	0.79	0.00	0.09	0.00	0.26
parietal lobe, fetal, donor1	10072-101I9	64.98	35.88	18.43	0.00	0.00	0.00	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	48.98	17.95	4.86	0.75	0.75	0.00	0.37	0.37
parotid gland, adult	10199-103F1	24.05	3.70	4.32	1.23	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	20.41	7.52	2.69	0.00	0.00	0.00	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	104.31	6.69	3.35	0.19	0.00	0.37	0.00	1.12
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	51.58	8.45	3.21	0.15	0.00	0.00	0.00	0.15
pineal gland - adult, donor10196	10179-103C8	18.06	6.45	0.00	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	40.86	22.50	4.15	2.96	0.59	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	18.19	11.29	3.14	1.25	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	42.50	7.08	4.05	1.01	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	58.89	9.90	2.61	3.65	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	27.24	8.51	3.40	0.00	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	29.35	17.09	4.95	0.86	0.22	0.54	0.00	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	39.60	2.78	2.52	0.13	0.00	0.00	0.13	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	30.51	18.68	4.05	0.93	0.00	0.00	0.00	0.00
pons, adult, pool1	10033-101E6	41.91	10.84	3.87	0.52	0.00	0.09	0.09	0.26
postcentral gyrus, adult, pool1	10032-101E5	31.91	6.54	1.83	1.22	0.00	0.09	0.00	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	50.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	38.89	4.52	3.64	0.29	0.15	0.00	0.00	0.15
prostate cancer cell line:PC-3	10439-106E7	46.65	9.44	3.63	0.18	0.00	0.00	0.00	0.00
prostate, adult, pool1	10022-101D4	21.95	9.25	2.81	0.27	0.00	0.09	0.00	0.18
putamen, adult, donor10196	10176-103C5	63.27	10.62	3.07	1.18	0.00	0.00	0.00	0.00
putamen, adult, donor10252	10152-102I8	35.29	11.76	0.00	0.00	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	24.04	4.37	1.09	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	39.38	6.28	2.42	0.72	0.00	0.00	0.00	0.00
putamen, newborn, donor10223	10365-105F5	35.98	9.00	6.75	0.75	0.00	0.75	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	135.28	13.38	9.31	0.29	0.00	0.00	0.00	1.45
rectum, fetal, donor1	10067-101I4	48.68	33.38	16.69	0.00	0.00	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	27.35	15.05	7.63	0.64	0.00	0.00	0.00	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	44.32	17.40	12.84	1.24	0.00	0.00	0.00	0.83
retina, adult, pool1	10030-101E3	20.68	7.75	1.49	1.49	0.00	0.00	0.00	0.00
retinoblastoma cell line:Y79	10475-106I7	104.70	28.84	10.39	2.08	0.26	0.00	0.00	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	35.29	9.10	3.93	0.00	0.00	0.00	0.00	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	44.71	5.91	1.69	0.00	0.00	0.00	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	18.19	20.46	4.55	0.00	1.52	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	18.13	11.17	3.40	0.32	0.32	0.00	0.00	0.16
salivary acinar cells, donor2	11772-123I8	16.66	11.01	2.62	0.55	0.69	0.00	0.00	0.14
salivary acinar cells, donor3	11773-123I9	11.92	11.92	2.65	0.66	1.99	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	14.30	5.15	0.57	1.14	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	109.94	18.63	10.12	1.26	0.00	0.17	0.00	1.69
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	110.85	17.52	8.23	0.35	0.82	0.12	0.00	1.41
seminal vesicle, adult	10201-103F3	14.81	15.87	3.70	0.00	0.00	0.53	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	21.38	9.72	2.43	0.00	0.49	0.00	0.00	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	51.08	35.23	7.30	0.50	0.75	0.75	0.00	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	50.18	42.15	16.06	0.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	40.03	5.37	1.75	0.54	0.00	0.00	0.00	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	90.08	19.89	7.07	0.99	0.11	0.00	0.00	0.99
signet ring carcinoma cell line:NUGC-4	10483-107A6	49.03	16.00	7.87	0.39	0.00	0.00	0.00	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	18.44	6.38	0.71	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	19.31	9.24	2.16	0.12	0.24	0.24	0.00	0.12
skeletal muscle, fetal, donor1	10066-101I3	14.07	8.04	0.00	0.00	0.00	2.01	0.00	0.00
skin, adult, donor1	10074-102A2	40.71	20.36	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	36.61	27.14	8.84	0.63	0.63	0.63	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	75.38	8.67	6.34	0.33	0.00	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	83.84	11.66	1.58	1.58	0.00	0.32	0.00	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	85.97	5.20	3.85	1.16	0.19	0.00	0.00	1.16
small cell lung carcinoma cell line:LK-2	10541-107H1	81.26	7.09	2.80	0.82	0.16	0.00	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	170.34	8.04	6.11	1.77	0.00	0.16	0.00	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	125.74	9.37	3.49	1.53	0.00	0.00	0.00	0.22
small intestine, adult, pool1	10024-101D6	53.99	18.16	7.64	1.43	0.00	0.00	0.00	0.48
small intestine, fetal, donor1	10064-101I1	33.41	13.02	6.63	0.00	0.00	0.25	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	107.71	15.90	5.13	1.03	0.00	0.00	0.51	1.03
smooth muscle, adult, pool1	10048-101G3	19.38	9.05	3.62	0.00	0.00	0.00	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	54.41	17.15	6.97	0.00	0.80	0.27	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	41.75	18.12	3.21	0.00	0.23	0.00	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	48.89	13.80	2.76	0.39	0.00	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	28.36	13.14	1.38	0.69	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	48.18	28.66	7.93	0.00	0.61	0.61	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	33.52	13.78	1.84	0.00	0.00	0.00	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	21.96	25.09	7.32	0.15	0.45	0.15	0.00	0.15
spleen, adult, pool1	10025-101D7	31.28	5.51	1.98	0.22	0.00	0.55	0.00	0.33
spleen, fetal, pool1	10044-101F8	30.83	9.38	3.50	2.22	0.08	1.51	0.00	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	34.37	4.66	2.59	0.31	0.00	0.00	0.00	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	33.99	3.80	2.85	0.19	0.00	0.00	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	27.26	4.54	2.80	0.35	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	64.11	16.81	5.86	0.00	0.00	0.00	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	84.87	2.48	1.24	0.79	0.00	0.00	0.11	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	30.08	13.98	5.51	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	36.81	11.00	7.19	0.00	0.42	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	59.81	13.88	1.07	0.00	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	22.79	10.82	7.98	0.00	0.00	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	53.59	14.33	2.91	0.21	0.00	0.00	0.00	0.21
substantia nigra, adult, donor10258	10371-105G2	32.59	9.31	1.03	0.00	0.00	0.52	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	36.04	14.13	0.71	0.71	0.00	0.00	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	44.71	10.32	3.90	0.23	0.00	0.00	0.00	0.23
temporal lobe, adult, pool1	10031-101E4	21.96	3.56	1.95	0.59	0.00	0.00	0.00	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	66.24	28.49	16.38	0.00	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	54.94	25.05	13.19	2.64	0.00	0.00	0.00	0.44
tenocyte, donor1	11763-123H8	25.83	20.95	2.44	0.00	0.00	0.00	0.00	0.70
tenocyte, donor2	11765-123I1	22.13	14.50	2.29	0.38	0.00	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	22.24	27.43	5.93	1.85	0.00	0.00	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	98.24	8.33	5.78	0.34	0.00	0.00	0.00	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	83.39	7.09	3.70	0.15	0.00	0.15	0.00	0.46
teratocarcinoma cell line:PA-1	10807-111A6	77.80	6.04	4.03	0.31	0.00	0.15	0.00	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	85.82	5.84	4.57	0.38	0.00	0.00	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	135.76	4.16	2.65	0.76	0.00	0.00	0.00	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	106.44	11.23	6.00	0.87	0.22	0.00	0.00	1.20
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	78.17	4.56	7.82	0.33	0.00	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	32.86	6.76	1.72	0.64	0.11	0.43	0.00	0.21
testis, adult, pool2	10096-102C6	46.01	4.06	1.80	0.45	0.45	0.00	0.00	0.00
thalamus - adult, donor10196	10168-103B6	29.81	7.73	3.31	0.00	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	55.95	14.22	3.91	0.94	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	30.79	10.78	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	18.45	6.09	1.65	0.16	0.16	0.00	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	21.29	12.66	2.88	0.00	0.00	0.00	0.58	0.00
throat, adult	10209-103G2	29.21	23.97	6.49	0.75	0.00	0.00	0.00	0.00
throat, fetal, donor1	10061-101H7	36.26	18.28	5.48	0.00	0.00	0.30	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	33.78	6.56	4.37	0.00	0.00	0.00	0.00	0.79
thymus, adult, pool1	10027-101D9	44.84	5.57	3.28	0.80	0.00	0.00	0.00	0.70
thymus, fetal, pool1	10043-101F7	49.77	11.43	2.91	2.18	0.00	0.10	0.00	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	31.91	12.63	4.12	0.13	0.13	0.00	0.00	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	54.62	4.47	1.68	0.42	0.00	0.00	0.00	0.14
thyroid, adult, pool1	10028-101E1	29.95	8.77	1.87	0.19	0.00	0.09	0.00	0.09
thyroid, fetal, donor1	10060-101H6	25.31	18.72	4.48	0.79	0.00	1.05	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	43.11	12.32	3.08	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	34.65	24.42	7.21	0.93	0.47	0.47	0.00	0.70
tongue, fetal, donor1	10059-101H5	44.53	24.83	8.28	0.39	0.00	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	50.29	27.45	8.72	2.20	0.40	0.20	0.00	0.40
trachea, adult, pool1	10029-101E2	29.04	11.04	4.34	0.33	0.00	0.25	0.00	0.33
trachea, fetal, donor1	10058-101H4	38.47	14.62	5.77	0.38	0.38	0.38	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	34.01	43.22	9.92	1.42	0.71	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	94.22	10.44	4.86	0.10	0.00	0.00	0.00	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	45.44	7.52	2.66	1.10	0.00	0.00	0.00	0.47
tridermal teratoma cell line:HGRT	10694-109G1	24.73	9.51	1.90	0.00	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	16.85	5.33	1.35	0.17	0.00	0.00	0.00	0.17
umbilical cord, fetal, donor1	10057-101H3	14.61	4.17	2.09	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	23.38	19.45	4.27	1.71	0.00	0.17	0.00	0.17
uterus, fetal, donor1	10055-101H1	36.86	26.62	5.12	0.00	0.00	0.51	0.00	0.00
vagina, adult	10204-103F6	25.20	15.51	5.82	0.65	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	20.60	11.84	4.16	1.97	0.00	0.88	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	37.92	2.14	3.20	0.80	0.00	0.00	0.00	0.53